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Summary 
During this work structural and functional analysis of RNA polymerase II (Pol II) was 
conducted. RNA polymerase II is the enzyme performing DNA transcription by syn-
thesising messenger RNAs in the nucleus of eukaryotic cells. Human cells can be 
infected by hepatitis B virus together with its satellite hepatitis D virus (HDV). The 
complementary RNA genome and antigenome of HDV are replicated by direct tran-
scription from each other without a reverse transcription step involving DNA. As HDV 
does not encode for a polymerase and its replication does not rely on hepatitis B vi-
rus, human host RNA polymerase was implicated to perform HDV replication. As a 
dedicated RNA-dependent RNA polymerase was not known in humans, DNA-
dependent RNA polymerases were hypothesised to perform RNA synthesis from 
HDV RNA templates. The first part of this work shows that Pol II from budding yeast 
Saccharomyces cerevisiae, which is closely related to human Pol II, indeed has 
RNA-dependent RNA polymerase activity in vitro. The activity is much slower and 
less processive than the DNA-dependent reaction. It could be a rudimentary activity 
of Pol II that was used during the theorised time of the “RNA world” earlier in evolu-
tion when RNA genomes existed and before DNA became the primary carrier of ge-
netic information. 
As Pol II is an elementary enzyme for cellular protein biogenesis it is an interesting 
object of regulative and mechanistic studies. Directed mutagenesis of Pol II can be 
used to analyse contributions of residues to enzyme activity both in vivo and in vitro. 
As Pol II cannot be reconstituted from recombinantly expressed subunits, mutations 
have to be introduced endogenously. To facilitate mutagenesis in yeast, a plasmid-
based mutagenesis system for the largest subunit Rpb1 was established within the 
second part of this work. Lethal mutations can be easily identified but corresponding 
enzymes could not be purified. Pol II mutants that are still capable of keeping cells 
viable were successfully cloned and purified. Pol II mutants produced based on the 
system are active in biochemical assays in vitro. The system opens up new opportu-
nities to generate various Pol II mutants to address diverse questions in Pol II-related 
studies. 
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1 Introduction 
1.1 DNA transcription in eukaryotes 
In living organisms genetic information is stored in the form of DNA. Transcription of 
genes encoded on DNA is performed by a single DNA-dependent RNA polymerase 
in prokaryotic cells. In the nucleus of eukaryotic cells, DNA is transcribed into RNA by 
three evolutionarily related but different types of polymerases. The three RNA poly-
merases show different sensitivities to the inhibitory mushroom toxin α-amanitin. 
Pol II is inhibited at low concentrations, yeast Pol I is much less sensitive and yeast 
Pol III activity is not affected by α-amanitin (Schultz & Hall, 1976) contrary to verte-
brate Pol I and Pol III (Schwartz et al., 1974). Pol I synthesises the precursor of 18S, 
5.8S and 28S rRNA. 5S rRNA and all tRNAs are produced by Pol III. Pol II tran-
scribes protein coding genes into mRNA and also synthesises small nuclear RNAs 
(Berg et al., 2002). Noncoding RNAs synthesised by Pol IV and Pol V, two additional 
RNA polymerases found only in plants, play a role in RNA interference (Matzke et al., 
2009). After processing of mRNA precursors ribosomes in the cytoplasm translate 
the mRNA-encoded information and synthesise proteins. 
1.2 RNA Pol II from S. cerevisiae 
Concerning sequence and structure, Pol II is homologous to Pol I and Pol III (Cramer 
et al., 2008) as well as to prokaryotic (Vassylyev et al., 2002; Zhang Y. et al., 2006) 
and archaeal RNA polymerases (Kusser et al., 2008). Pol II is strongly conserved 
from lower to higher eukaryotes. 53 % of the amino acid residues of Pol II from 
S. cerevisiae are identical to the human enzyme (Cramer et al., 2001). At least ten 
subunits encoded by human genes can replace their counterparts in yeast without 
loss of cell viability (Woychik, 1998). Thus yeast Pol II is as a good model and re-
search object and is representative of the human enzyme. 
1.2.1 Subunit composition and structure determination of Pol II 
Pol II has a molecular weight of 514 kDa comprised of twelve subunits (Rpb1–
Rpb12, Table 1) and is thus the smallest and simplest one of the three RNA poly-
Introduction 2 
 
merases (Cramer et al., 2008). Complete Pol II is formed by the ten-subunit core as-
sociated with the peripheral subunits Rpb4/7. Ten of the subunits are essential in 
yeast; Rpb4 and Rpb9 are not essential and both are positioned at the very outside 
of the protein complex (Figure 1). The Pol II core alone is sufficient for transcription 
elongation, while the dissociable Rpb4/7 subcomplex is essential for transcription 
initiation with only Rpb7 being indispensable (Edwards et al., 1991). 
Table 1: S. cerevisiae Pol II subunits. 
Subunit Mr Classification Subunit sharing Necessity 
Rpb1 191.6 kDa Ten-subunit core - Essential 
Rpb2 138.8 kDa Ten-subunit core - Essential 
Rpb3 35.3 kDa Ten-subunit core - Essential 
Rpb4 25.4 kDa Rpb4/7 subcomplex - Dispensable 
Rpb5 25.1 kDa Ten-subunit core With Pol I and Pol III Essential 
Rpb6 17.9 kDa Ten-subunit core With Pol I and Pol III Essential 
Rpb7 19.1 kDa Rpb4/7 subcomplex - Essential 
Rpb8 16.5 kDa Ten-subunit core With Pol I and Pol III Essential 
Rpb9 14.3 kDa Ten-subunit core - Dispensable 
Rpb10 8.3 kDa Ten-subunit core With Pol I and Pol III Essential 
Rpb11 13.6 kDa Ten-subunit core - Essential 
Rpb12 7.7 kDa Ten-subunit core With Pol I and Pol III Essential 
The X-ray structure of the Pol II core complex was solved at 2.8 Å resolution (Cramer 
et al., 2001), which served as basis for the structure of a core transcribing complex 
(Gnatt et al., 2001) and many following Pol II structures. By addition of recombinantly 
expressed Rpb4/7 X-ray crystallographic structure determination led to backbone 
models of complete Pol II at 4.2 Å and 4.1 Å resolution (Armache et al., 2003; 
Bushnell & Kornberg, 2003). By solving the structure of the Rpb4/7 subcomplex in-
dependently at 2.3 Å the complete Pol II model could be refined to 3.8 Å resulting in 
the first atomic model of complete Pol II (Armache et al., 2005). This could be used 
as search model to solve the structure of complete Pol II with bound DNA-RNA 
strands at 4.0 Å resolution (Kettenberger et al., 2004). Technical improvements of 
synchrotron hardware and processing programs yielded better quality of data. Up to 
present the highest resolved structure of a complete Pol II complex containing nucleic 
acids was obtained during Pol II fidelity studies at 3.2 Å (Sydow et al., 2009). 
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The Pol II model reveals that the two main parts of the enzyme primarily formed by 
the largest subunits Rpb1 and Rpb2 are separated by a deep cleft (Figure 1). The 
clamp located on one side of the cleft is a mobile element and comprises parts of the 
subunits Rpb1 and Rpb2 (Cramer et al., 2001). The clamp was observed in two con-
formations thus polymerase can adopt an open state as found in core Pol II struc-
tures (Cramer et al., 2000) or a closed state as in complete Pol II structures 
(Armache et al., 2003; Bushnell & Kornberg, 2003). Eight Zn2+ ions are bound to 
Pol II contributing to structural stabilisation (Cramer et al., 2001). At the active site 
two catalytically important Mg2+ ions bind. One Mg2+ ion (metal A) is stably coordi-
nated by three aspartates within the aspartate loop of Rpb1. The second Mg2+ ion 
(metal B) is delivered with incoming NTPs and thus exchanged between catalytic 
steps (Cramer et al., 2001). 
1.2.2 Structure and activity of the Pol II elongation complex 
Synthetic nucleic acid strands with appropriate sequences can be annealed to form 
complexes stabilised by Watson-Crick base pairs. Constructs resembling nucleic ac-
ids associated to a transcribing Pol II complex (Figure 2a) contain a DNA-RNA hybrid 
upstream of the active site and a DNA-DNA duplex region downstream. These pre-
Figure 1: Ribbon model of the complete Pol II (Armache et al., 2003). 
The views are from (a) the front and from (b) the top, respectively. Cyan spheres and a pink
sphere depict eight zinc ions and an active site magnesium ion, respectively. The linker to
the CTD is indicated as a dashed line. A key to subunit colour is shown in the bottom left
corner of (b), with subunits Rpb1–Rpb12 numbered 1–12. This Figure is adopted (Cramer,
2004). 
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formed nucleic acid scaffolds can be assembled with purified Pol II in vitro and sub-
jected to crystallisation or RNA elongation or cleavage experiments. The surface of 
the enzyme is generally negatively charged with the exception of the positively 
charged region covering the cleft, active site and wall (Cramer et al., 2001) 
(Figure 1). Negatively charged nucleic acids are accommodated in this positively 
charged cleft during elongation (Figure 2a). At the front of Pol II the DNA-template–
non-template duplex enters the cleft. The non-template is displaced from the tem-
plate strand and only the template reaches the active site (Figure 2a). The template 
is kinked about 90° and forms an 8–9 bp DNA–RNA hybrid upstream of the active 
site towards the wall (Figure 2c). The hybrid in the hybrid-binding site of Pol II has a 
conformation between A- and B-DNA (Gnatt et al., 2001). Conformational rear-
rangements of switch loops (Figure 2c) allow movement of the clamp to form a tran-
Figure 2: Structure of the Pol II EC. 
a, Overview of the EC structure (Kettenberger et al., 2004; Wang et al., 2006; Westover et
al., 2004). b, Superposition of NTP-binding sites: insertion site (Westover et al., 2004), entry
site (Westover et al., 2004) and inactive preinsertion-like state (Kettenberger et al., 2004) are
shown in, red, violet and pink, respectively. c, Functional Pol II surface elements in the EC. 
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scribing complex. The loops termed rudder, zipper and lid were suggested to be in-
volved in separation of RNA from template DNA at the upstream end of the hybrid 
(Cramer et al., 2001) (Figure 2c). 
RNA synthesis occurs by covalent nucleotide addition to the RNA’s 3’ end at the 
catalytic site. It discriminates against dNTPs and only an NTP that can form a Wat-
son-Crick bp with the templating dNTP (+1) is incorporated, with the trigger loop 
(Figure 2c) playing a role in substrate specificity (Wang et al., 2006). The fidelity of 
eukaryotic transcription is very high with an estimated nucleotide incorporation error 
probability of 10-5 (de Mercoyrol et al., 1992). 
After an NTP has bound to the insertion site (Figure 2b) the mobile trigger loop 
(Figure 2c) folds and closes the active site (Wang et al., 2006). Covalent bond forma-
tion between the incoming nucleotide and the RNA 3’-OH is catalysed by the two 
Mg2+ ions (metal A and B, Figure 2b) at the active site and inorganic pyrophosphate 
is released. This leaves Pol II in the pre-translocated state. Upstream translocation of 
nucleic acids relative to the enzyme involves a conformational change in the bridge 
helix, which is contacted by the trigger loop (Brueckner et al., 2009). The enzyme’s 
conformation is then in the post-translocated state with a free nucleotide insertion site 
and another nucleotide can be added by repeating the nucleotide addition cycle. 
1.2.3 The transcription cycle 
In vivo transcription of genes can be divided into three phases: initiation, elongation 
and termination. Initiation covers recruitment of polymerase to DNA and formation of 
a stable elongation complex which translocates along DNA during the elongation 
phase. The polymerase is released from the DNA in the termination phase. 
Many Pol II promoters contain a TA-rich element which is bound by TBP, a subunit of 
TFIID. Other factors can interact with alternative elements such as TFIIB, which in-
teracts with TFIIB recognition elements. TFIID is formed by TBP together with TBP-
associated factors that can apparently interact with Initiator and downstream pro-
moter elements (Sikorski T. W. & Buratowski, 2009) (Table 2). The binding of TBP 
introduces an approximately 90° kink in DNA (Kim J. L. et al., 1993a; Kim Y. et al., 
1993b), which serves as a saddle for binding of further factors. TFIIB bridges be-
tween the TBP-DNA complex and Pol II (Kostrewa et al., 2009) and thus recruits 
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complete Pol II with TFIIF to the promoter. TFIIE can then bind and melts the pro-
moter and recruits TFIIH which has DNA-dependent ATPase, helicase and kinase 
activities (Lee & Young, 2000). The Mediator, a huge multiprotein complex was found 
to promote transcription initiation by transmitting stimulatory effects from activators to 
the basal transcription machinery (Sikorski T. W. & Buratowski, 2009). 
Table 2: Protein complexes involved in Pol II preinitiation complex formation. This ta-
ble is adapted (Sikorski T. W. & Buratowski, 2009). 
Protein 
Complex 
Number of 
subunits 
Functions 
TFIIA 2–3 Functions to counteract repressive effects of negative cofactors; 
acts as a coactivator by interacting with activators and compo-
nents of the basal initiation machinery 
TFIIB 1 Stabilizes TFIID-promoter binding; aids in recruitment of 
TFIIF/Pol II to the promoter; directs accurate start site selection 
TFIID 14 
(TBP and 
TBP Associ-
ated Factors) 
Nucleates PIC assembly either through TBP binding to TATA 
sequences or TAF binding to other promoter sequences; coacti-
vator activity through direct interaction of TAFs and gene spe-
cific activators 
TFIIE 2 Helps recruit TFIIH to promoters; stimulates helicase and kinase 
activities of TFIIH; binds ssDNA and is essential for promoter 
melting 
TFIIF 2–3 Tightly associates with Pol II; enhances affinity of Pol II for TBP-
TFIIB-promoter complex; necessary for recruitment of 
TFIIE/TFIIH to the PIC; aids in start site selection and promoter 
escape; enhances elongation efficiency 
TFIIH 10 ATPase/helicase necessary for promoter opening and promoter 
clearance; helicase activity for transcription coupled DNA repair; 
kinase activity required for phosphorylation of Pol II CTD; facili-
tates transition from initiation to elongation 
Mediator ≥ 24 Bridges interaction between activators and basal factors; stimu-
lates both activator dependent and basal transcription; required 
for transcription from most Pol II dependent promoters 
As transcription starts, short RNA products are synthesised and released by Pol II 
during the abortive initiation phase. After promoter clearance processive RNA elon-
gation follows. Transitions between states are uniform for transcribed genes (Mayer 
et al., 2010) and involve formation of specific phosphorylation patterns at the hep-
tapetide repeats of the CTD of Rpb1 (Buratowski, 2009). The CTD is thus recognised 
by and serves as binding platform for different mRNA processing factors, such as the 
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capping enzyme that adds a 7-methylguanine triphosphate cap to the RNA’s 5’ end 
(Lee & Young, 2000). In parallel the RNA is elongated by Pol II and after passing the 
poly(A) site cleavage frees the nascent mRNA that can then be modified and ex-
ported into the cytoplasm to be translated. Release from the product RNA and tem-
plate DNA leads to Pol II termination that requires Rat1 and other factors (Dengl & 
Cramer, 2009). Free Pol II with an unphosphorylated CTD can then be recruited to 
another promoter, reinitiating the transcription cycle. 
1.3 Functional studies of Pol II by site-directed mutagenesis 
Site-directed mutagenesis allows for targeted studies e.g. of the precise contribution 
of single or multiple amino acid residues in enzyme-catalysed reactions. Mutagenesis 
studies are highly valuable to understand mechanisms of RNA polymerase function 
in detail. Archaeal RNA polymerases can be recombinantly expressed in E. coli and 
reconstituted from single subunits, enabling fast and easy studies of mutants (Naji et 
al., 2007; Werner & Weinzierl, 2002). Pol II in contrast could not be obtained by as-
sembly from recombinantly expressed subunits. Purified Pol II enzymes bearing mu-
tations can only be expressed endogenously. Thus mutations have to be introduced 
in the host organism. In yeast mutations can be introduced genomically, but an easier 
strategy is to use a plasmid-based approach, which additionally allows for identifica-
tion of lethal mutations. 
For Rpb2 (Table 1), a mutagenesis system was established allowing the introduction 
of mutations in Rpb2 and its galactose-inducible overexpression in S. cerevisiae 
(Domecq et al., 2010). The largest subunit Rpb1 mainly forms the active site region 
(Figure 1) and contains many functional elements of Pol II (Figure 2c) such as the 
zipper, lid, rudder, switch 2, active site aspartate loop, bridge helix, switch 1, switch 5 
(Cramer et al., 2001), trigger loop (Wang et al., 2006), clamp coiled coil (Kostrewa et 
al., 2009) and F loop (Miropolskaya et al., 2009). As Rpb1 covers a large portion of 
the Pol II surface and contains the CTD (1.2.3) it is of great importance when study-
ing Pol II interactions with external factors and transcriptional regulation. Thus a 
mutagenesis system of Rpb1 would open up new possibilities to study catalytic 
mechanisms as well as binding and effects of other factors on Pol II. 
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1.4 Implications for additional RdRP activity of Pol II and its 
role in HDV replication 
Chemically DNA is very similar to RNA. However, the presence of a 2’-OH group at 
the sugar of every base leads to another energetically more favourable sugar pucker 
of RNA. This is the basis for an RNA double strand to adopt A-DNA conformation 
while DNA generally exists as B-DNA under physiological conditions (Berg et al., 
2002). A free DNA-RNA hybrid adopts a conformation very similar to A-DNA (Horton 
& Finzel, 1996). This suggests itself that Pol II can possibly bind an RNA–RNA du-
plex in A-DNA conformation with only minor structural rearrangements in a similar 
manner as a DNA-RNA hybrid that is tightly bound to the enzyme during the process 
of transcription (Gnatt et al., 2001). In vitro an RNA–RNA duplex can be accommo-
dated in the enzyme’s hybrid binding site (Kettenberger et al., 2006). It was also dis-
covered that Pol II can synthesise RNA using homopolymeric RNAs as template 
(Dezelee et al., 1974). Stimulated by TFIIS, Pol II can cleave RNA and perform 3’ 
terminal NTP addition in the absence of DNA in vitro (Johnson & Chamberlin, 1994). 
In vivo there is also evidence that eukaryotic RNA polymerases contribute to RNA-
dependent RNA synthesis as e.g. in plants Pol II was implicated in the replication of 
viroids (Rackwitz et al., 1981). 
Infection of the human hepatitis B virus can be accompanied by infection of a satellite 
virus HDV that causes hepatitis D. The HDV genome is a circular, highly self-
complementary single-stranded RNA, which is the template for synthesis of the RNA 
antigenome and vice versa (Chao, 2007). Human Pol I and Pol II were predicted to 
play a role in the RNA-dependent replication of the RNA genome and antigenome of 
HDV as it does not include a reverse transcription step into DNA and there is no viral 
encoded polymerase (Lai, 2005). HDV RNA can be transcribed at least partially by 
Pol II in vitro (Filipovska & Konarska, 2000). In contrast to plant viroids, which do not 
code for polypeptides, HDV encodes for the protein HDAg. It is essential for HDV 
replication but is not a replicase itself (Filipovska & Konarska, 2000) and was found 
to bind to RNA Pol II and to stimulate transcription (Yamaguchi et al., 2001). 5’-
capping and 3’-polyadenylation are modifications that are only observed for Pol II 
transcripts as they are CTD-dependent (Lee & Young, 2000). HDAg mRNA was ob-
served in 5’-capped and 3’-polyadenylated states suggesting that its transcription 
templated by the genomic RNA strand of HDV is catalysed by Pol II (Gudima et al., 
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2000). HDV replication is sensitive to α-amanitin at concentrations specifically inhibit-
ing Pol II (MacNaughton et al., 1991; Moraleda & Taylor, 2001). As sensitivities to α-
amanitin of genomic and antigenomic strand replication differ, other polymerases 
than Pol II might as well be involved in HDV replication (Macnaughton et al., 2002; 
Modahl et al., 2000). A nucleolus-associated polymerase is also involved in HDV rep-
lication as immunofluorescence staining showed that genomic and antigenomic 
RNAs of HDV were found to occur at different intranuclear locations (Li et al., 2006). 
Overall these results suggest Pol II to be one of several activities that is responsible 
for HDV replication and transcription. New RdRPs have been recently discovered in 
human (Maida et al., 2009) and being involved in RNAi in Drosophila (Lipardi & 
Paterson, 2009). The detailed contribution of these RdRPs and Pol II within RdRP-
involving processes in eukaryotes is currently not clear. 
1.5 RNA polymerase-catalysed cleavage of product RNA 
The major function of RNA polymerases is to catalyse RNA synthesis by 3’ terminal 
NMP incorporation under release of pyrophosphate using NTPs as substrates (1.2.2). 
The back reaction comprising pyrophosphorolysis and release of an NTP is energeti-
cally unfavourable. However RNA cleavage can be catalysed by Pol II involving an 
attacking H2O molecule and is used during proofreading of transcription. As hydroly-
sis is a reaction distinct from pyrophosphorolysis and the reaction mechanism can be 
influenced by stimulatory factors, Pol II has a tunable active site (Sosunov et al., 
2003). During the process of transcription the net reaction is NTP incorporation re-
sulting in RNA elongation. However Pol II can encounter obstacles on the DNA dur-
ing the process of gene transcription and become arrested. In the process of back-
tracking Pol II translates upstream on the DNA template while the RNA 3’ end is ex-
truded through the enzyme’s pore (Cramer et al., 2008). Reactivation of arrested 
Pol II requires cleavage and release of the 3’ RNA. A free 3’ end realigned at the ac-
tive centre can then be used again as a substrate for elongation. 
1.5.1 Contribution of cleavage stimulatory factors 
Complete Pol II alone can perform dinucleotide cleavage when assembled with a 
9 bp hybrid including a mismatched 3’ nucleotide in vitro (Sydow et al., 2009). Pol II 
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lacking the non-essential subunit Rpb9 was shown to have similar intrinsic cleavage 
activities at mild alkaline conditions as wild-type Pol II (Weilbaecher et al., 2003). 
However, Rpb9 was implicated to play a role in this divalent cation-dependent weak 
intrinsic cleavage activity but its mechanism of action is still uncharacterised (Nesser 
et al., 2006). A strong cleavage activity of Pol II can be observed upon stimulation 
with TFIIS (Izban & Luse, 1992). In the Pol II-TFIIS complex TFIIS inserts a hairpin 
into the pore. Two adjacent carboxylic acid residues, the DE motif, at the hairpin’s tip 
coordinate metal B and a water molecule, which serves as the nucleophilic attacking 
moiety in RNA hydrolysis (Kettenberger et al., 2003). Arrested Pol II lacking Rpb9 
responds weakly to stimulation by TFIIS when testing read-through at transcription 
pause sites on DNA (Awrey et al., 1997). Both TFIIS and Rpb9 are not essential but 
a double-knock out is lethal in certain genetic backgrounds suggesting a redundant 
function. Consistently, both TFIIS and Rpb9 were found to play a role in Pol II tran-
scriptional fidelity (Koyama et al., 2007; Nesser et al., 2006) but detailed understand-
ing of their contributions in vivo is still missing. 
In Pol I and Pol III subunits A12.2 and C11, respectively are homologous to Rpb9 in 
Pol II. The C-terminus of A12.2 and C11 is related as well to the C-terminus of TFIIS, 
especially the two key acidic residues aspartate and glutamate are conserved in 
TFIIS, A12.2 and C11 but not in Rpb9, which contains residues aspartate and 
threonine instead. Pol I has a strong intrinsic cleavage activity that depends on sub-
unit A12.2 (Kuhn et al., 2007) in analogy to the cleavage activity of Pol III (Whitehall 
et al., 1994) that depends on C11 (Chedin et al., 1998). The Pol II structural model 
was fitted to an electron microscopic density of Pol III at 9.9 Å resolution. At the posi-
tion of the N-terminal domain of Rpb9 density was observed that was assigned to the 
homologous N-terminal domain of C11. As no additional density nearby could be as-
signed to the C11 C-terminal domain high flexibility was suggested (Fernández-
Tornero et al., 2010). In contrast to Rpb9, A12.2 and C11 thus seem to act as built-in 
cleavage stimulatory factors in Pol I and Pol III whose function in the Pol II system is 
conducted by the dissociable factor TFIIS. 
1.5.2 Role of functional polymerase elements in cleavage 
The RNA cleavage activity of eukaryotic RNA polymerases can be stimulated by ex-
ternal factors (1.5.1) or internal elements that transmit information to the active cen-
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tre. Functional elements near the active centre must then be directly involved in the 
cleavage procedure. The trigger loop is important for catalysis of NTP addition (Wang 
et al., 2006) (1.2.2) and a contribution to RNA hydrolysis seems plausible. However, 
in case of E. coli RNA polymerase intrinsic as well as factor-stimulated cleavage 
does not depend on refolding of the trigger loop, i.e. formation of trigger helices that 
form a metastable three helix bundle with the bridge helix (Zhang J. et al., 2010). But 
the trigger loop is not indispensable as a histidine residue in the trigger loop was 
found to be essential for RNA hydrolysis in studies with RNA polymerase of Thermus 
aquaticus and this role was suggested to be conserved among bacteria (Yuzenkova 
& Zenkin, 2010). The F loop, which is directly adjacent to the N-terminus of the bridge 
helix can contact the folded trigger loop, thus stabilising it in this conformation 
(Miropolskaya et al., 2009). Although it is essential for the RNA elongation activity of 
bacterial RNA polymerases the F loop does not play an essential role in RNA hy-
drolysis by Thermus aquaticus RNA polymerase (Miropolskaya et al., 2009). 
1.6 Aim of this work 
Based on the crystal structure of Pol II in complex with the FC* inhibitor RNA 
(Kettenberger et al., 2006), the question arose if Pol II can perform RNA templated 
nucleotide incorporation. Initial experiments with artificial RNA elongation scaffolds 
were promising (Lehmann, 2006). The RNA elongation and RNA hydrolysis activity of 
Pol II using artificial RNA–RNA scaffolds were characterised more in detail in this 
work, including visualisation of the RdRP elongation complex in a crystal structure. 
The possibilities and limits of Pol II’s RdRP activity within the process of HDV replica-
tion were studied. As in vitro setups allow for well-defined compositions of reaction 
mixtures containing only purified components, their results can complement former 
experiments using cell extracts or indirect assignments by α-amanitin resistance. 
This work’s in vitro studies on HDV replication should serve as a useful basis for tar-
geted experiments in vivo e.g. to find further stimulatory factors and thus to gain fur-
ther insights into the mechanism of HDV replication and in turn spreading of the virus. 
Detailed understanding of the HDV replication mechanism and contribution of in-
volved factors is necessary to find targets for drugs that can successfully decrease 
human pathogenic HDV propagation. 
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As Pol II cannot be reconstituted from recombinantly expressed subunits an Rpb1 
mutagenesis system in S. cerevisiae was developed within this work. To facilitate 
mutagenesis a strain containing plasmid-encoded Rpb1 was created. Although 
methods for gene knock-out, plasmid-transformation and sporulation are established 
in yeast, the challenge of this project was the huge size of this particular target gene, 
which makes all amplification and cloning steps technically more demanding than for 
a small gene. A well-established mutagenesis system in yeast that can be used for 
easy and convenient production of Rpb1-mutated Pol II complexes and that can be 
reproduced for other Pol II subunits was developed. 
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2 Materials and Methods 
2.1 Materials 
2.1.1 Bacterial and yeast strains 
Table 3: E. coli strains. 
Name Description Source 
BL21-CodonPlus (DE3)-
RIL 
E. coli B F– ompT hsdS(rB– mB–) dcm+ Tetr gal 
λ(DE3) endA Hte [argU ileY leuW Camr] 
Stratagene 
XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac 
[F’ proAB laclqZΔM15 Tn10 (Tetr)] 
Stratagene 
Table 4: S. cerevisiae strains. 
Name Description Source 
CB010Δrpb4 MATa pep4::HIS3, prb1::LEU2, prc1::HISG, 
can1, ade2, trp1, ura3, his3, leu2-3,112, 
rpb4::URA3 
(Edwards et 
al., 1990), 
(Fu et al., 
1999) 
BJ5464 MATα ura3-52 trp1 leu2-Δ1 his3-Δ200 
pep4::HIS3 prb1-Δ1.6R can1 GAL 
ATCC-LGC 
Standards 
BJ5465 MATa ura3-52 trp1 leu2-Δ1 his3-Δ200 
pep4::HIS3 prb1-Δ1.6R can1 GAL 
ATCC-LGC 
Standards 
BJ5626 MATα/MATa ura3-52/ura3-52 trp1/+ 
+/leu2-Δ1 his3-Δ200/his3-Δ200 
pep4::HIS3/pep4::HIS3 
prb1-Δ1.6R/prb1-Δ1.6R can1/can1 
GAL/GAL 
ATCC-LGC 
Standards 
BJ5464 Rpb3 His-Bio BJ5464 His-Bio tag introduced at 5’end of 
Rpb3 gene, use of URA3 selection marker 
(Kireeva et 
al., 2000b) 
BJ5464 Rpb3 His-Bio Δrpb9 BJ5464 Rpb3 His-Bio rpb9::NatNT2 This study 
BJ5626 Δrpb1/+ BJ5626 rpb1::kanMX6/Rpb1 This study 
BJ5626 Δrpb1/+ 
pRS316-Rpb1 
BJ5626 rpb1::kanMX6/Rpb1 
pRS316-Rpb1 
This study 
BJ5626 Δrpb1/+ 
pRS316-Rpb1 
pRS31N-Pep4-Prb1 
BJ5626 rpb1::kanMX6/Rpb1 
pRS316-Rpb1 pRS31N-Pep4-Prb1 
This study 
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Name Description Source 
BJ5464 Δrpb1 pRS316-Rpb1 BJ5464 rpb1::kanMX6 pRS316-Rpb1 This study 
BJ5465 Δrpb1 pRS316-Rpb1 BJ5465 rpb1::kanMX6 pRS316-Rpb1 This study 
BJ5464 Δrpb1 pRS315-Rpb1 BJ5464 rpb1::kanMX6 pRS315-Rpb1 This study 
BJ5464 Δrpb1  
pRS315-Rpb1-N-H10 
BJ5464 rpb1::kanMX6 
pRS315-Rpb1-N-H10(SA)5 
This study 
BJ5464 Δrpb1 
pRS315-Rpb1-C-H10 
BJ5464 rpb1::kanMX6 
pRS315-Rpb1-C-H10 
This study 
BJ5464 Δrpb1 pRS316-Rpb1 
pRS315-Rpb1-Δlid1-C-H10 
BJ5464 rpb1::kanMX6 pRS316-Rpb1 
pRS315-Rpb1-Δlid1-C-H10 
This study 
BJ5464 Δrpb1 pRS316-Rpb1 
pRS315-Rpb1-Δlid2-C-H10 
BJ5464 rpb1::kanMX6 pRS316-Rpb1 
pRS315-Rpb1-Δlid2-C-H10 
This study 
BJ5464 Δrpb1 pRS316-Rpb1 
pRS315-Tet-Rpb1-Δlid2-C-H10 
BJ5464 rpb1::kanMX6 pRS316-Rpb1 
pRS315-Tet-Rpb1-Δlid2-C-H10 
This study 
BJ5464 Δrpb1  
pRS315-Rpb1-FIII-C-H10 
BJ5464 rpb1::kanMX6 
pRS315-Rpb1-FIII-C-H10 
This study 
BJ5464 Δrpb1 
pRS315-Rpb1-ccc2R-C-H10 
BJ5464 rpb1::kanMX6 
pRS315-Rpb1-ccc2R-C-H10 
This study 
BJ5464 Δrpb1 
pRS315-Rpb1-ccc7A-C-H10 
BJ5464 rpb1::kanMX6 
pRS315-Rpb1-ccc7A-C-H10 
This study 
BJ5464 Δrpb1 
pRS315-Rpb1-I756K-C-H10 
BJ5464 rpb1::kanMX6 pRS315-Rpb1-
I756K-C-H10 
This study 
BJ5464 Δrpb1 
pRS315-Rpb1-D1359K-C-H10 
BJ5464 rpb1::kanMX6 
pRS315-Rpb1-D1359K-C-H10 
This study 
BJ5464 Δrpb1 
pRS315-Rpb1-G1360Q-C-H10 
BJ5464 rpb1::kanMX6 
pRS315-Rpb1-G1360Q-C-H10 
This study 
BJ5464 Δrpb1 Δrpb9 
pRS316-Rpb1 
BJ5464 rpb1::kanMX6 rpb9::natNT2 
pRS316-Rpb1 
This study 
BJ5464 Δrpb1 Δrpb9 
pRS315-Rpb1-C-H10 
BJ5464 rpb1::kanMX6 rpb9::natNT2 
pRS315-Rpb1-C-H10 
This study 
BJ5464 Δrpb1 Δrpb9 
pRS315-Rpb1-FIII-C-His 
BJ5464 rpb1::kanMX6 rpb9::natNT2 
pRS315-Rpb1-FIII-C-H10 
This study 
BJ5464 Δrpb1 Δrpb9 
pRS315-Rpb1-I756K-C-H10 
BJ5464 rpb1::kanMX6 rpb9::natNT2 
pRS315-Rpb1-I756K-C-H10 
This study 
BJ5464 Δrpb1 Δrpb9 
pRS315-Rpb1-D1359K-C-H10 
BJ5464 rpb1::kanMX6 rpb9::natNT2 
pRS315-Rpb1-D1359K-C-H10 
This study 
BJ5464 Δrpb1 Δrpb9 
pRS315-Rpb1-G1360Q-C-H10 
BJ5464 rpb1::kanMX6 rpb9::natNT2 
pRS315-Rpb1-G1360Q-C-H10 
This study 
BJ5464 Δrpb1 Δdst1 
pRS315-Rpb1-C-H10 
BJ5464 rpb1::kanMX6 dst1::Trp1 
pRS315-Rpb1-C-H10 
This study 
Materials and Methods – Materials 15 
 
Name Description Source 
BY4741 MATa his3-Δ1 leu2-Δ0 met15-Δ0 ura3-Δ Euroscarf 
BY4742 MATα his3-Δ1 leu2-Δ0 lys2-Δ0 ura3-Δ0 Euroscarf 
BY4743 MATα/MATa his3-Δ1/his3-Δ1 
leu2-Δ0/leu2-Δ0; met15-Δ0/MET15; 
LYS2/lys2-Δ0; ura3-Δ0/ura3-Δ0 
Euroscarf 
BY4743 Δrpb1/+ BY4743 rpb1::kanMX6/Rpb1 This study 
BY4743 Δrpb1/+ 
pRS316-Rpb1 
BY4743 rpb1::kanMX6/Rpb1 
pRS316-Rpb1 
This study 
BY4741 Δrpb1 pRS316-Rpb1 BY4741 rpb1::kanMX6 pRS316-Rpb1 This study 
BY4742 Δrpb1 pRS316-Rpb1 BY4742 rpb1::kanMX6 pRS316-Rpb1 This study 
2.1.2 Plasmids 
Table 5: Bacterial expression plasmid. 
Name Backbone Insert Insertion sites1 Source 
pET-21b(+)-
Rpb4/7 
pET-21b(+) Rpb4, Rpb7-C-H6 NdeI/XhoI (Sakurai et al., 
1999) 
Table 6: Plasmids used as templates for cassette amplification by PCR. 
Name Cassette Source 
pFA6a-kanMX6 kanMX6 (Wach et al., 1994) 
pFA6a-natNT2 natNT2 (Janke et al., 2004) 
pCM251 Tet-on promoter with two copies of tetO (Bellí et al., 1998) 
Table 7: Yeast plasmids. 
Name Backbone Insert Insertion sites1 Source 
pRS315 pRS315 - - (Sikorski R. S. & 
Hieter, 1989) 
pRS316 pRS316 - - (Sikorski R. S. & 
Hieter, 1989) 
pRS315-Rpb1 pRS315 Rpb12 XhoI/SacI This study 
pRS316-Rpb1 pRS316 Rpb12 XhoI/SacI This study 
pRS315-Rpb1-N-H10 pRS315 Rpb1-N-H10-(SA)52 XhoI/SacI This study 
                                                            
1 The insertion site listed first corresponds to the upstream end of the insert. 
2 The insert corresponds to the ORF with naturally flanking sequences 523 bp upstream and 281 bp 
downstream. 
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Name Backbone Insert Insertion sites1 Source 
pRS315-Rpb1-C-H10 pRS315 Rpb1-C-H102 XhoI/SacI This study 
pRS315-Rpb1-Δlid1-
C-H10 
pRS315 Rpb1-Δlid1-C-H102 XhoI/SacI This study 
pRS315-Rpb1-Δlid2-
C-H10 
pRS315 Rpb1-Δlid2-C-H102 XhoI/SacI This study 
pRS315-Tet-Rpb1-
Δlid2-C-H10 
pRS315 Tet-Rpb1-Δlid2-C-
H103 
XhoI/SacI This study 
pRS315-Rpb1-FIII-
C-H10 
pRS315 Rpb1-FIII-C-H102 XhoI/SacI This study 
pRS315-Rpb1-CTD-
C-H10 
pRS315 Rpb1-CTD-C-H102 XhoI/SacI This study 
pRS315-Rpb1-TEV-
C-H10 
pRS315 Rpb1-TEV-C-H102 XhoI/SacI This study 
pRS315-Rpb1-
ccc2R-C-H10 
pRS315 Rpb1-ccc2R-C-
H102 
XhoI/SacI This study 
pRS315-Rpb1-
ccc7A-C-H10 
pRS315 Rpb1-ccc7A-C-
H102 
XhoI/SacI This study 
pRS315-Rpb1-
I756K-C-H10 
pRS315 Rpb1-I756K-C-
H102 
XhoI/SacI This study 
pRS315-Rpb1-
D1359K-C-H10 
pRS315 Rpb1-D1359K-C-
H102 
XhoI/SacI This study 
pRS315-Rpb1-
G1360Q-C-H10 
pRS315 Rpb1-G1360Q-C-
H102 
XhoI/SacI This study 
pRS31N-Pep4-Prb1 pRS31N4 Pep45, Prb16 BamHI/XhoI, 
NotI/BamHI 
This study 
   
                                                            
3 The insert corresponds to the ORF with a Tet-on promoter upstream and the naturally flanking se-
quence 281 bp downstream. 
4The backbone corresponds to pRS316 with the ura3 ORF replaced by an insertion of the natNT2 
sequence at NdeI/NsiI1 sites. 
5 The insert corresponds to the ORF with naturally flanking sequences 500 bp upstream and 195 bp 
downstream. 
6 The insert corresponds to the ORF with naturally flanking sequences 500 bp upstream and 200 bp 
downstream. 
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2.1.3 Synthetic oligonucleotides 
Table 8: DNA oligonucleotide used in RNA elongation experiments.7 
Name Sequence8 Source 
FB-DNA1-EL TCGAGGTAGCTTGACGCCTGGTCAAA metabion 
Table 9: RNA oligonucleotides used in RNA elongation experiments.7 
Name Sequence8 Source 
KB-RNA1-flu FAM-UGCAUAAAGACCAGGC9 biomers.net 
KB-RNA1-
blunt-flu 
FAM-UUUGACCAGGC9 biomers.net 
FB-RNA1 UCGAGGUAGCUUGACGCCUGGUCAAA biomers.net 
FB-RNA1-4bp UCAGGUAGCUGAC GCCUGGUCAAA biomers.net 
FB-RNA1-6bp UCGAAGGUAGCUUUGACGCCUGGUCAAA biomers.net 
FB-RNA1-ss6 CUUGACGCCUGGUCAAA biomers.net 
FB-RNA1-ss10 GUAGCUUGACGCCUGGUCAAA biomers.net 
FB-RNA1-mut1 UCGAGCGACCUUGACGCCUGGUCAAA biomers.net 
FB-RNA1-mut2 UCGAGGCAGCUUGACGCCUGGUCAAA metabion 
HDV-cleaved-
flu 
FAM-UAGAGAGAUUUUUUUCUCUCGAUUCUCUAUCGG 
AAU9 
biomers.net 
HDV-AG-clAG-
36-flu 
FAM-UAGAGAGAUUUUUUUCUCUCGAUUCUAGAUCGG 
AAU9 
biomers.net 
HDV-AG-cl-U-
17-flu 
FAM-UGAUUCUCUAUCGGAAU9 biomers.net 
HDV-AG-cl-U-
18-flu 
FAM-UGAUUCUCUAUCGGAAUC9 biomers.net 
HDV-AG-cl-UA-
19 
UGAUUCUCUAUCGGAAUCA metabion 
HDV-cleaved-
loopC-FAM 
FAM-UAGAGAGAUUUUUCUCUCUCGAUUCUCUAUCGG 
AAU9 
metabion 
HDV-AG-cl-48-
flu 
FAM-UAGAGAGAUUUGUGGGGAGCCACUUUUCUCUCG 
AUUCUCUAUCGGAAU9 
metabion 
RNAfusion1 
FC*-HDV 
FAM-UCGAGGUAGCUUGACAUUCUCUAUCGGAAU9 metabion 
                                                            
7 Oligonucleotides were HPLC-purified, delivered lyophilised and dissolved in TE buffer to a final con-
centration of 400 μM. 
8 Oligonucleotide sequences are shown in the 5‘ to 3‘ direction. 
9 Oligonucleotide labelled with 6-carboxyfluorescein (FAM) at 5’ end. 
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Name Sequence8 Source 
RNAfusion2 
HDV-EC-tem 
UAGAGAGAUUUUUUUCUCUCG GCCUGGUCAAA metabion 
HDV-AG-cl-21-
FAM 
FAM-CUCGAUUCUCUAUCGGAAUCG9 metabion 
HDV-AG-cl-27-
FAM 
FAM-UCUCUCGAUUCUCUAUCGGAAUCGAGA9 metabion 
HDV-AG-cl-33-
FAM 
FAM-UUUUCUCUCGAUUCUCUAUCGGAAUCGAGAGAA9 metabion 
HDV-AG-cl-37-
FAM 
FAM-UUUUUUCUCUCGAUUCUCUAUCGGAAUCGAGAG 
AAAA9 
metabion 
HDV-AG-cl-43-
art-FAM 
FAM-GAUUUUUUUCUCUCGAUUCUCUAUCGGAAUCGA 
GAGAAAAAAA9 
metabion 
HDV-AG-cl-43-
nat-FAM 
FAM-GCCACUUUUCUCUCGAUUCUCUAUCGGAAUCGA 
GAGAAAAGUG9 
metabion 
HDV-AG-uncl-
31-flu 
FAM-UCUCUCGAUUCUCUAUCGGAAUCUAGAGAGA9 biomers.net 
HDV-uncl-35-
GCCG-FAM 
FAM-CUUUGCCCUCGAUUCUCUAUCGGAAUCUAGAGG 
GC9 
metabion 
HDV-AG-
11nont 
UAGAGAGAUUU metabion 
HDV-AG-
25tem-FAM 
FAM-UUUUCUCUCGAUUCUCUAUCGGAAU9 metabion 
pCPG79 RNA-
28-FAM 
FAM-GGUCCGGGAUCUGGAUCCAGAUCCCGGA9 metabion 
HDV-AG-cl-51-
bulge-FAM 
FAM-AAGGGAGAGCCACUUUUCUAGUAAUUCUCUAUC 
GGAAUCGAGAGAAAAGUG9 
metabion 
Table 10: DNA oligonucleotides used as PCR primers.10 
Name Sequence8 Source 
1_Sc_Rpb1_310bp_up_
f 
TCCCTGATCAACTTTCAAGG Thermo Fisher 
Scientific 
2_Sc_Rpb1_20bp_up_K
anMX6_5’_r 
CCTTAATAACCCGGGGATCCGGTCTGATTTA 
TATTTTGGGG 
Thermo Fisher 
Scientific 
3_Sc_Rpb1_20bp_up_K
anMX6_5’_f 
CCCCAAAATATAAATCGACCGGATCCCCGG 
GTTAATTAAGG 
Thermo Fisher 
Scientific 
4_Sc_KanMX6_3’_Rpb
1_20bp_down_r 
CGTAAGGATGATATACTATAGAATTCGAGCT 
CGTTTAAACTGG 
Thermo Fisher 
Scientific 
                                                            
10 Oligonucleotides were HPLC-purified, delivered lyophilised and dissolved in H2O to a final concen-
tration of 100 μM. 
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Name Sequence8 Source 
5_Sc_KanMX6_3’_ 
Rpb1_20bp_down_f 
CCAGTTTAAACGAGCTCGAATTCTATAGTAT 
ATCATCCTTACG 
Thermo Fisher 
Scientific 
6_Sc_Rpb1_232bp_ 
down_r 
GCTTAGAAGTTGGACGGACG Thermo Fisher 
Scientific 
7_Sc_Rpb1_500bp_up_
XhoI_f 
TGCTAGCTCTCGAGAGAGGTATCATAAGAA 
CATCCG 
Thermo Fisher 
Scientific 
8_Sc_Rpb1-
EagI_down_BamHI_r 
AGCTAGCAGGATCCTTACCCTTCAAACGAG 
CACG 
Thermo Fisher 
Scientific 
11_Sc_Rpb1-
BspHI_up_f 
GTTAGAGAATATTACATTACGTGG Thermo Fisher 
Scientific 
12_Sc_Rpb1_260bp_ 
down_SacI_r 
AGCTAGCAGAGCTCAAGAGCTTAATTGCTA 
AAAAGG 
Thermo Fisher 
Scientific 
17_Sc_Rpb1_R247: 
D261_r 
CAGCAAGTTTAAAGGTTAAATCACGCACCG 
GTGG 
Thermo Fisher 
Scientific 
18_Sc_Rpb1_R247: 
D261_f 
CCACCGGTGCGTGATTTAACCTTTAAACTTG 
CTG 
Thermo Fisher 
Scientific 
19_Sc_Rpb1_P248: 
D260_r 
GCAAGTTTAAAGGTTAAATCATCTGGACGCA 
CCGG 
Thermo Fisher 
Scientific 
20_Sc_Rpb1_P248: 
D260_f 
CCGGTGCGTCCAGATGATTTAACCTTTAAAC 
TTGC 
Thermo Fisher 
Scientific 
27_Teton_pCM251_ 
PspOMI_f 
TGCTAGCTGGGCCCATCCTCGCGCCCCC Thermo Fisher 
Scientific 
28_Sc_Rpb1_Teton_ 
BamHI_r 
GCACTAGAATACTGTTGTCCTACCATACGG 
ATCCCCCGAATTG 
Thermo Fisher 
Scientific 
29_Sc_Rpb1_Teton_ 
BamHI_f 
CAATTCGGGGGATCCGTATGGTAGGACAAC 
AGTATTCTAGTGC 
Thermo Fisher 
Scientific 
24_Sc_Rpb1_FIII_r GAAATGAGGTAAGGTACGATCTTGGAACCC Thermo Fisher 
Scientific 
25_Sc_Rpb1_FIII_f GATCGTACCTTACCTCATTTCCCCAAAAATT 
CGAAATCCCCAG 
Thermo Fisher 
Scientific 
26_Sc_Rpb1-
BsiWI_down _r 
GAGACGTGGCTTCACC Thermo Fisher 
Scientific 
14_Sc_Rpb1_2485bp_f AGGTCTTATCGATACCGCCG Thermo Fisher 
Scientific 
30_Sc_Rpb1_ 
TEV1488_r 
ACCTTGAAAGTACAAATTTTCTTTAACGTCA 
AGATCTGCATTG 
Thermo Fisher 
Scientific 
31_Sc_Rpb1_ 
TEV1488_f 
GAAAATTTGTACTTTCAAGGTCTGGTTGATT 
CGGG 
Thermo Fisher 
Scientific 
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Name Sequence8 Source 
32_Sc_Rpb1-
BsiWI_up_f 
GACGCTATGGCTGGAGG Thermo Fisher 
Scientific 
33_Sc_Rpb1_9hep_r GTTCGTCTTGCTTTGGCGAATATGATGGTG 
ACG 
Thermo Fisher 
Scientific 
34_Sc_Rpb1_9hep_f CGTCACCATCATATTCGCCAAAGCAAGACG 
AAC 
Thermo Fisher 
Scientific 
35_Sc_Rpb1_ccc2R_r GTGGCCTTCTGTTATGCTCTAGTGTTTCCAA 
AC 
Thermo Fisher 
Scientific 
36_Sc_Rpb1_ccc2R_f GCATAACAGAAGGCCACATCATGCTATTGA 
AG 
Thermo Fisher 
Scientific 
37_Sc_Rpb1_ccc7A_r CAGCGGCGGCAGCTGCCTCTAGTGTTTCCA 
AACTAATATTAGC 
Thermo Fisher 
Scientific 
38_Sc_Rpb1_ccc7A_f TGCCGCCGCTGCAGCTGCTATTGAAGAAGC 
AGAGAG 
Thermo Fisher 
Scientific 
39_Sc_Rpb1_I756K_f GGGTTCATTTAAAAATATCGCG Thermo Fisher 
Scientific 
40_Sc_Rpb1_I756K_r CGCGATATTTTTAAATGAACCC Thermo Fisher 
Scientific 
41_Sc_Rpb1_D1359K_f GTTATTGCTTCTAAAGGTTCGTATG Thermo Fisher 
Scientific 
42_Sc_Rpb1_D1359K_r CATACGAACCTTTAGAAGCAATAAC Thermo Fisher 
Scientific 
43_Sc_Rpb1_G1360Q_
f 
ATTGCTTCTGATCAATCGTATGTT Thermo Fisher 
Scientific 
44_Sc_Rpb1_G1360Q_
r 
AACATACGATTGATCAGAAGCAAT Thermo Fisher 
Scientific 
Sc_Rpb1_C-term-H10_f CACCACCATCACCACCATCACCACCATCACT 
GATATAGTATATCATCCTTACG 
Thermo Fisher 
Scientific 
Sc_Rpb1_C-term-H10_r GTGATGGTGGTGATGGTGGTGATGGTGGTG 
TCTGGAATTTTCATTTTCATTAT 
Thermo Fisher 
Scientific 
Sc_Rpb1_N-term-
H10AS5_f 
CACCACCATCACCACCATCACCACCATCACT 
CAGCGTCAGCGTCAGCGTCAGCGTCAGCGG 
TAGGACAACAGTATTCTAGTG 
Thermo Fisher 
Scientific 
Sc_Rpb1_N-term-
H10AS5_r 
CGCTGACGCTGACGCTGACGCTGACGCTGA 
GTGATGGTGGTGATGGTGGTGATGGTGGTG 
CATGTCTGATTTATATTTTGGGG 
Thermo Fisher 
Scientific 
Sc_Pep4_500bp_up_ 
BamHI_f 
TGCTAGCTGGATCCCGTTTTCAATATCTTGA 
GCTCCTCAATTG 
Thermo Fisher 
Scientific 
Sc_Pep4_200bp_down_
XhoI_r 
AGCTAGCACTCGAGCCGCATCATCGGGC Thermo Fisher 
Scientific 
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Name Sequence8 Source 
Sc_Prb1_500bp_up_ 
NotI_f 
TGCTAGCTGCGGCCGCCCCGACAAATCAGC 
CACTAAC 
Thermo Fisher 
Scientific 
Sc_Prb1_200bp_down_
BamHI_r 
AGCTAGCAGGATCCAAAAACGCAAATATGTA 
GTAATACGTGG 
Thermo Fisher 
Scientific 
pFA6a_S1_NdeI_f TGCTAGCTCATATGCGTACGCTGCAGGTCG 
AC 
Thermo Fisher 
Scientific 
pFA6a_S2_NsiI_r AGCTAGCAATGCATATCGATGAATTCGAGCT 
CG 
Thermo Fisher 
Scientific 
Sc_Rpb9_KO_S1_f CAAAATCTAGCCAAAAGAGCAAGTTAAACTC 
CCCTTAAAACTGCTATGCGTACGCTGCAGG 
TCGAC 
Thermo Fisher 
Scientific 
Sc_Rpb9_KO_S2_r CATTTTCTCTCCCTCTGTCATTAATTTTGAAA 
GTTCGTTGAGCACTCAATCGATGAATTCGAG 
CTCG 
Thermo Fisher 
Scientific 
Mating_type_1 AGTCACATCAAGATCGTTTATGG Thermo Fisher 
Scientific 
Mating_type_2 GCACGGAATATGGGACTACTTCG Thermo Fisher 
Scientific 
Mating_type_3 ACTCCACTTCAAGTAAGAGTTTG Thermo Fisher 
Scientific 
Table 11: DNA oligonucleotides used as sequencing primers.10 
Name Sequence8 Source 
natNT2_outfor CGCTCTACATGAGCATGCCCTGCCC Thermo Fisher 
Scientific 
Sc_Rpb9_test_pr_f AGCAGATTCTAGGTAGAACG Thermo Fisher 
Scientific 
Sc_Rpb9_test_pr_r CATACGTGAAGATAAGTCCC Thermo Fisher 
Scientific 
9_Sc_Rpb1-EagI_up_f AATGATATTGCTGGTCAACC Thermo Fisher 
Scientific 
10_Sc_Rpb1-
BspHI_down_BamHI_r 
AGCTAGCA GGATCCTTGGACTTGGTACTTT 
ACGG 
Thermo Fisher 
Scientific 
13_Sc_Rpb1_1704bp_f CACCTGCAATTATCAAGCCC Thermo Fisher 
Scientific 
14_Sc_Rpb1_2485bp_f AGGTCTTATCGATACCGCCG Thermo Fisher 
Scientific 
15_Sc_Rpb1_854bp_f CTAGAGCATAACGGTGCTCC Thermo Fisher 
Scientific 
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Name Sequence8 Source 
16_Sc_Rpb1_3734bp_f CGTTGTCGTGTTGTTCGTCC Thermo Fisher 
Scientific 
45_Sc_Rpb1_Xba1_ 
down_r 
GCGCAGCATCCATACC Thermo Fisher 
Scientific 
M13uni (-21) TGTAAAACGACGGCCAGT Provided by 
sequencing 
company 
M13rev (-29) CAGGAAACAGCTATGACC Provided by 
sequencing 
company 
2.1.4 Media 
Table 12: Media for E. coli cultivation. 
Name Description11 
LB 1 % (w/v) Bacto tryptone, 0.5 % (w/v) yeast extract, 8.6 mM NaCl, 
2.6 mM NaOH, plates contained 1.5 % (w/v) agar 
ZY 1 % (w/v) tryptone, 0.5 % (w/v) yeast extract, used with 5052 and NPS 
(Table 13) 
Table 13: Additives for E. coli media. 
Name Stock solution11 Applied concentration 
50 × 5052 25 % (w/v) glycerol, 2.5 % (w/v) glu-
cose, 10 % (w/v) α-lactose 
0.5 % (w/v) glycerol, 0.05 % (w/v) 
glucose, 0.2 % (w/v) α-lactose 
20 × NPS 0.5 M (NH4)2SO4, 1 M KH2PO4, 1 M 
Na2HPO4 
25 mM (NH4)2SO4, 50 mM 
KH2PO4, 50 mM Na2HPO4 
Ampicillin 10 % (w/v) ampicillin 0.1 % (w/v) ampicillin 
Tetracycline 1.25 % (w/v) tetracycline in EtOH 0.00125 % (w/v) tetracycline 
IPTG 1 M IPTG 2 mM IPTG 
   
                                                            
11If not specified, chemicals used to prepare buffers and solutions had p.a. quality and were produced 
by one of the following companies: Bio-Rad, Fluka, Invitrogen, Merck, Riedel-de Haën, Roth, Sigma-
Aldrich or VWR. If not stated otherwise buffers and mixtures were aqueous solutions. 
Materials and Methods – Materials 23 
 
Table 14: Media for S. cerevisiae cultivation. 
Name Description11 
YP 1.5 % (w/v) yeast extract, 2 % (w/v) peptone 
YPD YP, 2 % (w/v) glucose, plates contained 2 % (w/v) agar 
YPD, clonNAT plates YPD plates, 0.01 % (w/v) clonNAT 
YPD, G-418 plates YPD plates, 0.04 % (w/v) G-418 (~0.3 U/l G-418) 
SC -Leu 0.69 % (w/v) YNB, 0.069 % (w/v) CSM -Leu, 2 % (w/v) glucose 
SC -His plates 0.69 % (w/v) YNB, 0.077 % (w/v) CSM -His, 2 % (w/v) agar, 2 % 
(w/v) glucose 
SC -Leu plates 0.69 % (w/v) YNB, 0.069 % (w/v) CSM -Leu, 2 % (w/v) agar, 2 % 
(w/v) glucose 
SC -Trp plates 0.69 % (w/v) YNB, 0.074 % (w/v) CSM -Trp, 2 % (w/v) agar, 2 % 
(w/v) glucose 
SC -Ura plates 0.69 % (w/v) YNB, 0.077 % (w/v) CSM -Ura, 2 % (w/v) agar, 2 % 
(w/v) glucose 
SC -Ura, clonNAT plates 0.69 % (w/v) YNB, 0.077 % (w/v) CSM -Ura, 2 % (w/v) agar, 2 % 
(w/v) glucose, 0.01 % clonNAT 
SC -Leu, -Ura plates 0.69 % (w/v) YNB, 0.067 % (w/v) CSM -Leu, -Ura, 2 % (w/v) 
agar, 2 % (w/v) glucose 
5-FOA plates 0.69 % (w/v) YNB, 0.077 % (w/v) CSM -Ura, 0.002 % (w/v) uracil, 
0.1 % (w/v) 5-FOA, 2 % (w/v) agar, 2 % (w/v) glucose 
Sporulation plates 100 mM NaOAc, 25.5 mM KCl, 2.9 mM MgSO4 · 7 H2O, 
20.5 mM NaCl, 1.5 % (w/v) agar 
Table 15: Additives and components for S. cerevisiae media. 
Name Source Stock solution11 Applied concentration 
Ampicillin Roth 10 % (w/v) ampicillin 0.005 % (w/v) ampicillin 
Tetracycline Roth 1.25 % (w/v) tetracycline 
in EtOH 
0.00125 % (w/v) tetracycline 
Antifoam C 
emulsion 
Sigma-
Aldrich 
100 % (v/v) antifoam C 
emulsion 
0.1 % (v/v) antifoam C emul-
sion 
ClonNAT Werner Bio-
Agents 
10 % (w/v) clonNAT 0.01 % (w/v) clonNAT 
G-418 Formedium 20 % (w/v) G-418 (~150 
U/l G-418) 
0.04 % (w/v) G-418 (~0.3 U/l 
G-418) 
6-azauracil Sigma-
Aldrich 
100 mg/ml in DMSO 50–200 µg/ml 
YNB Formedium - 0.69 % (w/v) YNB 
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Name Source Stock solution11 Applied concentration 
CSM -His Formedium - 0.077 % (w/v) CSM -His 
CSM -Leu Formedium - 0.069 % (w/v) CSM -Leu 
CSM -Trp Formedium - 0.074 % (w/v) CSM -Trp 
CSM -Ura Formedium - 0.077 % (w/v) CSM -Ura 
CSM -Leu, -Ura  Formedium - 0.067 % (w/v) CSM -Leu, -Ura 
2.1.5 Buffers, markers, solutions and enzymes 
Table 16: General buffers, dyes, markers and solutions. 
Name Description11 or source 
100 × PI 60 µM leupeptin, 200 µM pepstatin A, 98 mM PMSF, 
211 mM benzamidine; in EtOH 
4 × stacking gel buffer 0.5 M Tris-HCl, 0.4 % SDS (w/v), pH 6.8 
4 × separation gel buffer 3 M Tris-HCl, 0.4 % SDS (w/v), pH 8.85 
Tris-glycine running buffer 25 mM Tris, 250 mM glycine, 0.1 % (w/v) SDS 
MES running buffer 50 mM MES, 50 mM Tris, 0.1 % (w/v) SDS, 1 mM EDTA 
5  × SDS loading dye 25 % (v/v) glycerol, 7.5 % (w/v) SDS, 250 mM Tris-Cl 
(pH 6.8 at 20 °C), 0.5 % (w/v) bromophenol blue, 12.5 % 
(v/v) β-mercaptoethanol 
1  × SDS loading dye 5 % (v/v) glycerol, 1.5 % (w/v) SDS, 50 mM Tris-Cl (pH 6.8 
at 20 °C), 0.1 % (w/v) bromophenol blue, 2.5 % (v/v) 
β-mercaptoethanol 
Broad range molecular weight 
marker 
Bio-Rad 
Coomassie stain 50 % (v/v) ethanol, 7 % (v/v) acetic acid, 0.125 % (w/v) 
Coomassie Brilliant Blue R-250  
Destain 7 % (v/v) acetic acid, 5 % (v/v) ethanol 
Ethidium bromide solution 1 % Roth 
SYBR Safe DNA gel stain, 
10,000 × concentrate in 
DMSO 
Invitrogen 
TBE 90 mM Tris, 90 mM boric acid, 2 mM EDTA (pH 8.0) 
6 × DNA loading dye Fermentas 
Gene Ruler 1 kb DNA ladder 
0.1 µg/µl 
Fermentas 
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Table 17: Buffers used for preparation of chemically competent E. coli cells. 
Name Description11 
TFB-I 30 mM KOAc (pH 5.8 at 22 °C), 50 mM MnCl2, 100 mM RbCl, 10 mM 
CaCl2, 15 % (v/v) glycerol  
TFB-II 10 mM MOPS (pH 7.0 at 4 °C), 75 mM CaCl2, 10 mM RbCl, 15 % (v/v) 
glycerol 
Table 18: Buffers used for Pol II purification via immunoaffinity chromatography. 
Name Description11 
3 × freezing buffer 150 mM Tris-Cl (pH 7.9 at 4 °C), 3 mM EDTA, 30 μM ZnCl2, 
30 % (v/v) glycerol, 3 % (v/v) DMSO, 30 mM DTT, 3 × PI 
Heparin column 
storage buffer 
50 mM NaOAc, 20 % (v/v) ethanol 
HSB150 50 mM Tris-Cl (pH 7.9 at 4 °C), 150 mM KCl, 1 mM EDTA, 
10 μM ZnCl2, 10 % (v/v) glycerol, 10 mM DTT, 1 × PI 
HSB600 50 mM Tris-Cl (pH 7.9 at 4 °C), 600 mM KCl, 1 mM EDTA, 
10 μM ZnCl2, 10 % (v/v) glycerol, 10 mM DTT, 1 × PI 
TEZ0 50 mM Tris-Cl (pH 7.5 at 20 °C), 1 mM EDTA, 10 μM ZnCl2, 
1 mM DTT, 1 × PI 
TEZ250 10 % (v/v) 10 × TEZ0, 250 mM (NH4)2SO4, 1 mM DTT, 1 × PI 
TEZ250-azide 10 % (v/v) 10 × TEZ0, 250 mM (NH4)2SO4, 0.02 % azide 
TEZ500 10 % (v/v) 10 × TEZ0, 500 mM (NH4)2SO4, 1 mM DTT, 1 × PI 
TEZ500-glycerol 10 % (v/v) 10 × TEZ0, 500 mM (NH4)2SO4, 50 % (v/v) glycerol, 
1 mM DTT 
TEZ500-ethylene 
glycol 
10 % (v/v) 10 × TEZ0, 500 mM (NH4)2SO4, 70 % (v/v) ethylene glycol 
Pol II buffer 5 mM HEPES (pH 7.25 at 20 °C), 40 mM (NH4)2SO4, 10 µM ZnCl2, 
10 mM DTT 
Table 19: Buffers used for Pol II purification via Ni-NTA affinity chromatography. 
Name Description11 
3 × freezing buffer 150 mM Tris-Cl (pH 7.9 at 4 °C), 3 mM EDTA, 30 μM ZnCl2, 30 % (v/v) 
glycerol, 3 % (v/v) DMSO, 30 mM DTT, 3 × PI 
HSB150/0 50 mM Tris-Cl (pH 7.9 at 4 °C), 150 mM KCl, 1 mM EDTA, 10 μM 
ZnCl2, 10 % (v/v) glycerol, 10 mM DTT, 1 × PI 
HSB0/0 50 mM Tris-Cl (pH 7.9 at 4 °C), 1 mM EDTA, 10 μM ZnCl2, 10 % (v/v) 
glycerol, 2.5 mM DTT, 1 × PI 
HSB1000/7 50 mM Tris-Cl (pH 7.9 at 4 °C), 1000 mM KCl, 1 mM EDTA, 10 μM 
ZnCl2, 7 mM imidazole, 10 % (v/v) glycerol, 2.5 mM DTT, 1 × PI 
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Name Description11 
Ni buffer0 20 mM Tris-HCl (pH 7.9 at 4 °C), 150 mM KCl, 10 μM ZnCl2, 2.5 mM 
DTT, 1 × PI 
Ni buffer7 20 mM Tris-HCl (pH 7.9 at 4 °C), 150 mM KCl, 10 μM ZnCl2, 7 mM imi-
dazole,  2.5 mM DTT, 1 × PI 
Ni buffer50 20 mM Tris-HCl (pH 7.9 at 4 °C), 150 mM KCl, 10 μM ZnCl2, 50 mM 
imidazole,  2.5 mM DTT, 1 × PI 
Ni buffer100 20 mM Tris-HCl (pH 7.9 at 4 °C), 150 mM KCl, 10 μM ZnCl2, 100 mM 
imidazole,  2.5 mM DTT, 1 × PI 
Ni buffer200 20 mM Tris-HCl (pH 7.9 at 4 °C), 150 mM KCl, 10 μM ZnCl2, 200 mM 
imidazole,  2.5 mM DTT, 1 × PI 
Ni buffer300 20 mM Tris-HCl (pH 7.9 at 4 °C), 150 mM KCl, 10 μM ZnCl2, 300 mM 
imidazole,  2.5 mM DTT, 1 × PI 
MonoQ0 20 mM Tris-acetate (pH 7.9 at 4 °C), 0.5 mM EDTA, 10 μM ZnCl2, 10 % 
glycerol, 10 mM DTT 
MonoQ150 20 mM Tris-acetate (pH 7.9 at 4 °C), 0.5 mM EDTA, 10 μM ZnCl2, 10 % 
glycerol, 150 mM KOAc, 10 mM DTT 
MonoQ2000 20 mM Tris-acetate (pH 7.9 at 4 °C), 0.5 mM EDTA, 10 μM ZnCl2, 10 % 
glycerol, 2 M KOAc, 10 mM DTT (pH 7.9 at 4 °C) 
Pol II buffer 5 mM HEPES (pH 7.25 at 20 °C), 40 mM (NH4)2SO4, 10 µM ZnCl2, 
10 mM DTT 
Table 20: Buffers used for Rpb4/7 purification. 
Name Description11 
Rpb4/7 freezing 
buffer 
50 mM Tris (pH 7.0 at 4 °C), 150 mM NaCl, 10 % glycerol, 10 mM 
β-mercaptoethanol, 1 × PI 
Buffer0 50 mM Tris (pH 7.5 at 4 °C), 150 mM NaCl, 10 mM β-mercaptoethanol, 
1 × PI 
Buffer10 50 mM Tris (pH 7.5 at 4 °C), 150 mM NaCl, 10 mM imidazole, 10 mM 
β-mercaptoethanol, 1 × PI 
Buffer20 50 mM Tris (pH 7.5 at 4 °C), 150 mM NaCl, 20 mM imidazole, 10 mM 
β-mercaptoethanol, 1 × PI 
Buffer50 50 mM Tris (pH 7.5 at 4 °C), 150 mM NaCl, 50 mM imidazole, 10 mM 
β-mercaptoethanol, 1 × PI 
Buffer200 50 mM Tris (pH 7.5 at 4 °C), 150 mM NaCl, 200 mM imidazole, 10 mM 
β-mercaptoethanol, 1 × PI 
Salt buffer 50 mM Tris (pH 7.5 at 4 °C), 2 M NaCl, 10 mM β-mercaptoethanol, 
1 × PI 
SourceQ0 20 mM Tris (pH 7.5 at 4 °C), 1 mM EDTA, 10 mM DTT 
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Name Description11 
SourceQ100 20 mM Tris (pH 7.5 at 4 °C), 100 mM NaCl, 1 mM EDTA, 10 mM DTT 
SourceQ2000 20 mM Tris (pH 7.5 at 4 °C), 2 M NaCl, 1 mM EDTA, 10 mM DTT 
Pol II buffer 5 mM HEPES (pH 7.25 at 20 °C), 40 mM (NH4)2SO4, 10 µM ZnCl2, 
10 mM DTT 
Table 21: Buffers used for crystallisation. 
Name Description11 
Pol II buffer 5 mM HEPES (pH 7.25 at 20 °C), 40 mM (NH4)2SO4, 10 µM ZnCl2, 
10 mM DTT 
NH4OAc–
Mg(OAc)2 
mother solution 
50 mM HEPES (pH 7.0 at 20 °C), 140, 170 or 200 mM NH4OAc, 
150 mM Mg(OAc)2, 3.5, 4.0, 4.5 or 5.0 % (w/v) PEG 6000, 5 mM TCEP 
NH4OAc–
Mg(OAc)2 
cryo solution 
50 mM HEPES (pH 7.0 at 20  °C), 140, 170 or 200 mM NH4OAc, 
150 mM Mg(OAc)2, 3.5, 4.0, 4.5 or 5.0 % (w/v) PEG 6000, 5 mM TCEP
20 % (w/v) glycerol 
NH4OAc–NaOAc 
mother solution 
50 mM HEPES (pH 7.0 at 20 °C), 140, 170 or 200 mM NH4OAc, 
300 mM NaOAc, 4.0, 4.5, 5.0, 5.5, 6.0, 6.5, 7.0 % (w/v) PEG 6000, 
5 mM TCEP 
NH4OAc–NaOAc 
cryo solution 
50 mM HEPES (pH 7.0 at 20 °C), 200 mM NH4OAc, 300 mM NaOAc, , 
4.0, 4.5, 5.0, 5.5, 6.0, 6.5, 7.0 % (w/v) PEG 6000, 5 mM TCEP, 
22 % (w/v) glycerol 
Table 22: Buffers, solutions and components used for RNA elongation experiments. 
Name Description11 or source 
TE TRIS–EDTA Buffer Solution (pH 7.4), BioChemika Ultra (Sigma-
Aldrich) 
TE 20 mM HEPES (pH 7.6 at 20 °C), 60 mM (NH4)2SO4, 8 mM MgSO4, 
10 µM ZnCl2, 10 % (v/v) glycerol, 10 mM DTT 
100 mM ATP Fermentas 
100 mM CTP Fermentas 
100 mM GTP Fermentas 
100 mM UTP Fermentas 
2 × urea loading 
dye 
180 mM Tris, 180 mM boric acid, 4 mM EDTA (pH 8.0), 8 M urea, 
0.03 % (w/v) bromophenol blue, 0.03 % (w/v) xylene cyanol FF 
2 × urea loading 
buffer 
180 mM Tris, 180 mM boric acid, 4 mM EDTA (pH 8.0), 8 M urea 
TBE 90 mM Tris, 90 mM boric acid, 2 mM EDTA (pH 8.0) 
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Name Description11 or source 
Rotiphorese NF-
Acrylamide/ 
Bis-solution 40 % 
(19:1) 
Roth 
Rotiphorese NF-
Urea 
Roth 
Table 23: Enzymes, buffers and components used for PCR and plasmid cloning. 
Name Source 
dNTP mix, 2 mM each Fermentas 
dNTPs (100 mM; 25 mM each dNTP) Stratagene 
DMSO Stratagene 
Herculase II Fusion DNA Polymerase Stratagene 
5 × Herculase II Reaction Buffer Stratagene 
Phusion High-Fidelity DNA polymerase 
(2 U/µl) 
Finnzymes (ordered at New England Biolabs) 
Phusion Hot Start High-Fidelity DNA po-
lymerase (2 U/µl) 
Finnzymes (ordered at New England Biolabs) 
5 × Phusion HF Buffer Finnzymes (ordered at New England Biolabs) 
Pwo SuperYield DNA polymerase (5 U/µl) Roche 
Pwo SuperYield PCR buffer Roche 
Taq DNA Polymerase (recombinant) Fermentas 
10 × Taq Buffer with KCl Fermentas 
25 mM MgCl2 Fermentas 
ApaI (50,000 U/ml) New England Biolabs 
BamHI (20,000 U/ml) New England Biolabs 
BsiWI (10,000 U/ml) New England Biolabs 
EagI (10,000 U/ml) New England Biolabs 
NsiI (10,000 U/ml) New England Biolabs 
SacI (20,000 U/ml) New England Biolabs 
XhoI (20,000 U/ml) New England Biolabs 
10 × NEBuffer 1, 2, 3 or 4 New England Biolabs 
100 × BSA New England Biolabs 
T4 DNA Ligase New England Biolabs 
10 × T4 DNA Ligase Reaction Buffer New England Biolabs 
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Table 24: Buffers used for yeast cloning experiments. 
Name Description11 
TELit 155 mM LiOAc, 10 mM Tris/HCl (pH 8.0), 1 mM EDTA (pH 8.0) 
LitSorb 18.2 % (w/v) D-sorbitol in TELit 
LitPEG 40 % (w/v) PEG 3350 in TELit 
One-step buffer 0.2 M LiOAc, 40 % (w/v) PEG 3350, 100 mM DTT 
LiOAc/DTT 0.1 M LiOAc, 30 mM DTT 
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2.2 Methods 
2.2.1 Plasmid cloning and amplification in E. coli cells 
2.2.1.1 DNA amplification by polymerase chain reaction 
PCR primers were designed to have a melting temperature of 50–65 °C and if possi-
ble having at least one C or G residue at their 3’ ends. If primers contained a restric-
tion enzyme recognition site an eight nucleotide overhang was included in the primer 
at its 5’ end. A typical PCR reaction mixture with a volume of 50 µl contained 100–
200 ng template DNA (plasmid or genomic DNA or PCR product), 0.5 µM of each 
DNA primer, 200 µM dNTPs and the standard concentration of the respective reac-
tion buffer and enzyme (2.1.5, Table 23). For most applications Phu-
sion High Fidelity DNA polymerase (Finnzymes) was best suited. PCR reactions 
were run in a T3000 Thermocycler (Biometra). Annealing temperature and extension 
time were adapted to the respective primers and length of desired amplification prod-
uct according to polymerase supplier’s information. 5 µl of the PCR reaction volume 
were analysed by agarose gel electrophoresis (2.2.3). PCR products were purified 
following the QIAquick PCR Purification Kit Protocol (QIAGEN). 
2.2.1.2 Enzymatic restriction digest 
Enzymatic restriction digests were usually performed in a volume of 50 µl. DNA ob-
tained in one PCR reaction (2.2.1.1) or 1–5 µg of plasmid DNA were digested with 
DNA restriction enzymes (New England Biolabs) according to manufacturer’s rec-
ommendations. Digested DNA was purified following the QIAquick Gel Extraction Kit 
Protocol (QIAGEN). 
2.2.1.3 Enzymatic plasmid ligation 
DNA amounts of insert and plasmid backbone were estimated analysing 1 µl each by 
agarose gel electrophoresis (2.2.3) and considering the respective length of frag-
ments. Besides T4 DNA Ligase (New England Biolabs) and corresponding buffer the 
20 µl ligation reaction mixture contained digested insert and plasmid with 2-10 fold 
molar excess of insert. For ligation the mixture was incubated for 1 h at 22 °C. 
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2.2.1.4 Plasmid transformation into E. coli cells 
2.2.1.4.1 Transformation into chemically competent cells 
Chemically competent E. coli (2.2.1.7.1) cells were thawed on ice. 1 µl plasmid DNA 
solution (2.2.1.5) or 10 µl ligation mixture (2.2.1.3) were added to the cell suspension 
and incubated for 5 min on ice, then incubated for 30 s at 42 °C, incubated for 1 min 
on ice and then plated on an LB-Amp plate (2.1.4, Table 12, Table 13) for selection. 
The plate was incubated overnight at 37 °C. 
2.2.1.4.2 Transformation into electrocompetent cells 
Electrocompetent E. coli cells (2.2.2.3.3.2) were thawed on ice. 3–5 µl ligation mix-
ture (2.2.1.3) were added to the cell suspension and incubated for 5 min on ice. The 
mixture was transferred into a prechilled Gene Pulser cuvette (0.2 cm gap, Bio-Rad) 
and pulsed with 2.5 kV using a MicroPulser electroporation apparatus (Bio-Rad). 
200 µl LB were added, cell suspension was transferred into a 1.5 ml reaction tube 
and incubated for 30 min at 37 °C, shaking at 600 rpm and plated on an LB-Amp 
plate for selection. The plate was incubated 20–24 h at 37 °C. 
2.2.1.5 Plasmid amplification and isolation 
To isolate plasmid DNA from XL1-blue cells (2.1.1, Table 3) 5 ml LB-Amp were in-
oculated with a single colony from an LB-Amp plate (2.2.1.4, 2.2.1.6) and incubated 
overnight at 37 °C, shaking at 160 rpm for cell growth. Cells were harvested by cen-
trifugation (10 min, 3,900 × g, 4 °C). Plasmid DNA was isolated according to the 
QIAprep Miniprep Protocol (QIAGEN). Due to the high yield of pRS plasmids (2.1.2) 
these plasmids were eluted from the spin columns with 100 µl H2O. 
2.2.1.6 Sequence verification of isolated plasmids by test restriction di-
gest or colony PCR and sequencing 
To verify the correct construction of clones it was first checked whether the desired 
insert was contained in isolated plasmid clones (2.2.1.5). Therefore, a test restriction 
digest was performed in a volume of 20 µl, containing 1 µl plasmid DNA, 0.3 µl of 
each restriction enzyme and buffer (2.1.5, Table 23) and incubated for 1 h at the re-
spective temperature. Alternatively for easier analysis of large amounts of clones a 
colony PCR was performed to amplify the desired insert. The PCR reaction mixture 
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of 50 µl contained 0.64 µM of each primer, 150 µM dNTPs, 2 % DMSO and 
2.5 mM  MgCl2, 1.5 U Taq DNA polymerase (Fermentas) and 1 × Taq Pol buffer + 
KCl. To add template DNA a colony from the transformation plate (2.2.1.4) was 
picked with a plastic inoculation loop and dipped into the PCR reaction mixture. Then 
the same loop was used to streak the cells on an LB-Amp plate that was then incu-
bated overnight at 37 °C. Colony PCR reactions were run as described (2.2.1.1.) 
20 µl of the test restriction digest mixture or 15 µl of the colony PCR mixture were 
analysed by agarose gel electrophoresis (2.2.3). After colony PCR only plasmid 
clones known to contain the desired insert were then subjected to plasmid amplifica-
tion and isolation (2.2.1.5). A clone that was positively tested to contain the insert 
was then analysed in detail by sequencing the insert and ligation region. Sequencing 
was performed by Eurofins MWG Operon or at GATC Biotech providing template and 
primer amounts as requested by the respective company. 
2.2.1.7 Preparation of competent E. coli cells for plasmid transformation 
2.2.1.7.1 Chemically competent E. coli cells 
500 ml LB with antibiotic (2.1.4, Table 12, Table 13) were inoculated with 10 ml of an 
overnight culture of the desired strain (2.1.1, Table 3) and incubated at 37 °C, shak-
ing at 160 rpm until an OD600 of 0.5 was reached. Cells were cooled on ice for 
10 min. In the following the sample was permanently treated on ice or at 4 °C. Cells 
of 450 ml culture were harvested by centrifugation (10 min, 3,700 × g) and resus-
pended in 100 ml TFB-I (2.1.5, Table 17). The suspension was centrifuged (10 min at 
3,700 × g) resuspended in 8 ml TFB-II (2.1.5, Table 17). Aliquots of 50 µl were frozen 
in liquid N2 and stored at -80 °C. 
2.2.1.7.2 Electrocompetent E. coli cells 
For better transformation efficiency after ligation electrocompetent XL1-blue cells 
(2.1.1, Table 3) were prepared. 2 l LB were inoculated with 20 ml of an overnight cul-
ture and incubated at 37 °C, shaking at 160 rpm, until an OD600 of 0.5 was reached. 
Cells were cooled on ice for 15 min. In the following the sample was always kept on 
ice or at 4 °C. Cells were harvested by centrifugation (10 min, 1,000 × g). Cells were 
resuspended in 800 ml sterile H2O. The suspension was centrifuged (10 min, 
1,000 × g) and cells were resuspended in 400 ml sterile H2O. Centrifugation was re-
peated and cells were resuspended in 20 ml sterile 10 % (v/v) glycerol. After centrifu-
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gation (10 min, 5,000 × g) cells were resuspended in 3 ml sterile 10 % (v/v) glycerol. 
Aliquots of 50 µl were frozen in liquid N2 and stored at -80 °C. 
2.2.2 Vector-based and genomic cloning with S. cerevisiae cells 
2.2.2.1 General treatment of yeast cultures and storage of strains 
Liquid yeast cultures were continuously checked for absence of contaminants using a 
light microscope (Leica DM LS, Leica). For long-term storage of strains as glycerol 
stock a mixture of an overnight culture with 25 % (v/v) glycerol was stored at -80 °C. 
For regular use cells were incubated on appropriate selective plates for cell growth 
(2.1.4, Table 14, Table 15) and then stored at 4 °C. After 3–4 weeks cells were re-
streaked on a fresh plate. After restreaking cells for ten times cells from a glycerol 
stock were streaked on a fresh plate. 
2.2.2.2 Plasmid transformation into S. cerevisiae cells and selection of 
transformants 
A pinhead size amount of cells was scraped from a plate and suspended in 1 ml ster-
ile H2O. Cells were pelleted by centrifugation (1 min, 15,000 × g, room temperature 
(RT)). Cells were resuspended in 100 µl one-step buffer (2.1.5, Table 24). 
0.2 % (w/v) salmon sperm DNA (Sigma-Aldrich) was incubated 10 min at 95 °C and 
shock-cooled on ice. 10 µl salmon sperm DNA solution was mixed with 2 µl plasmid 
DNA solution (2.2.1.5). 100 µl cell suspension in one-step buffer were added to the 
DNA solution. The mixture was incubated 30 min at 45 °C, then 1 ml sterile H2O was 
added. Cells were pelleted by centrifugation (10 s, 15,000 × g, RT), resuspended in 
100 µl H2O, plated on a selection plate, which was incubated for two nights at 30 °C. 
2.2.2.3 Introduction of genomic mutations in S. cerevisiae cells by ho-
mologous recombination 
2.2.2.3.1 DNA amplification by PCR 
DNA to be used for homologous recombination in S. cerevisiae was amplified as de-
scribed (2.2.1.1) with the following changes: presence of the full recombination se-
quence in the primers results in very long primers of 65–70 b that can make a suc-
cessful amplification difficult due to formation of secondary structures. In this case a 
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reduced concentration of 0.025 µM of each primer and 12 ng template plasmid DNA 
were used in the PCR reaction mixture. For amplification of the GC-rich natNT2 cas-
sette from pFA6a-natNT2 (2.1.2, Table 6) Herculase II Fusion DNA Polymerase 
(Stratagene) was used in presence of 2 % (v/v) DMSO. To obtain highly concentrated 
DNA sufficient for transformation and homologous recombination five PCR setups of 
50 µl each were run in parallel and pooled. DNA was purified using the QIAquick 
PCR Purification Kit Protocol (QIAGEN) or alternatively after agarose gel electropho-
resis (2.2.3) by the QIAquick Gel Extraction Kit Protocol (QIAGEN). 
2.2.2.3.2 Transformation of linear DNA into S. cerevisiae cells 
2.2.2.3.2.1 Transformation into chemically competent S. cerevisiae cells 
0.5–5 µg purified DNA (2.2.2.3.1) in a volume not exceeding 10 µl were added to a 
50 µl suspension of competent cells (2.2.2.3.3.1). 360 µl LitPEG (2.1.5, Table 24) 
were added and incubated for 30 min at RT. 47 µl DMSO were added and incubated 
for 10 min at 30 °C, then 5 min at 37 °C and cells were pelleted by centrifugation 
(3 min, 350 × g, RT). Cells were resuspended in 1 ml YPD and incubated for 3 h, 
shaking at 500 rpm for recovery at 30 °C or 24 °C if temperature-sensitivity of the 
mutant strain might be possible. Centrifugation was repeated; cells were resus-
pended in 100 µl H2O and plated on a selective plate. The plate was incubated at 
30 °C or 24 °C as before for several days until colonies appeared. 
2.2.2.3.2.2 Transformation into electrocompetent S. cerevisiae cells 
250 ng DNA, solved in H2O (2.2.2.3.1) was added to 100 µl cell suspension 
(2.2.2.3.3.2), transferred into a prechilled Gene Pulser cuvette (0.2 cm gap, Bio-Rad) 
and pulsed with 2.5 kV using a MicroPulser electroporation apparatus (Bio-Rad). 1 ml 
YPD (30 °C) was added; the cell suspension was transferred to a 2 ml Eppendorf 
reaction tube and incubated for 1 h at 30 °C, shaking at 350 rpm. After centrifugation 
(10 s, 350 × g, RT) cells were resuspended in 100 µl H2O, plated on a selective plate 
and incubated at 30 °C for 2–3 days. 
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2.2.2.3.3 Preparation of competent S. cerevisiae cells for homologous re-
combination 
2.2.2.3.3.1 Chemically competent S. cerevisiae cells 
100 ml YPD were inoculated with an overnight culture at a starting OD600 of 0.2 and 
incubated at 30 °C, shaking at 150 rpm until OD600 was 0.5–0.7. Cells of 50 ml cul-
ture were harvested by centrifugation (5 min, 3,900 × g, 22 °C) and resuspended in 
25 ml sterile H2O. Centrifugation was repeated and cells were resuspended in 5 ml 
LitSorb (2.1.5, Table 24) and after another centrifugation in 360 µl LitSorb. 
0.2 % (w/v) salmon sperm DNA (Sigma-Aldrich) was heated 10 min at 95 °C and 
shock-cooled on ice. 40 µl salmon sperm DNA were added to the cell suspension. 
50 µl aliquots were used immediately for transformation (2.2.2.3.2.1) or alternatively 
stored at -80 °C. 
2.2.2.3.3.2 Electrocompetent S. cerevisiae cells 
500 ml YPD were inoculated with an overnight culture at a starting OD600 of 0.15 and 
incubated at 30 °C, shaking at 150 rpm until OD600 was 0.7–0.8. Cells of 100 ml cul-
ture were harvested by centrifugation (5 min, 4,900 × g, 4 °C). In the following the 
sample was permanently treated on ice or at 4 °C. Centrifugation was repeated to 
wash cells two times with 50 ml H2O and then with 50 ml 1 M D-sorbitol. Cells were 
then resupended in 20 ml LiOAc/DTT (2.1.5, Table 24) and incubated for 30–60 min 
at 30 °C, shaking at 160 rpm. Then the sample was again permanently treated on ice 
or at 4 °C. Cells were washed two times with 50 ml 1 M D-sorbitol, including centrifu-
gation as described above. Cells were resuspended in 1 ml 1 M D-sorbitol, centri-
fuged (1 min, 1,500 × g) and finally a cell pellet of 100 µl volume was resuspended in 
50 µl 1 M D-sorbitol. 
2.2.2.3.4 Verification of genomic mutation by colony PCR 
Clones obtained after transformation (2.2.2.3.2) were verified as successful transfor-
mants by colony PCR. A pinhead size amount of yeast cells was suspended in 100 µl 
0.02 M NaOH and 50–100 µl soda lime glass beads (Ø = 0.5 mm, BioSpec Products) 
were added. The suspension was incubated for 5 min at 99 °C, shaking at 1,400 rpm 
and then centrifuged (15 s, 20,000 × g, RT). 5 µl of the DNA-containing supernatant 
provided the template for a colony PCR that was set up and run as described 
(2.2.1.6). Amplification primers were designed such that the presence or size of an 
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amplification product proved the presence of the genomic mutation at the intended 
locus. 
2.2.2.4 Sporulation of diploid S. cerevisiae cells, tetrad dissection and 
isolation of haploid clones 
Diploid S. cerevisiae cells were incubated on a sporulation plate (2.1.4, Table 14) at 
30 °C for 100–120 h to stimulate sporulation. Cells were scratched from the plate, 
resuspended in 500 µl H2O, centrifuged (15 s, 20,000 × g, RT) and washed with 
500 µl H2O. Centrifugation was repeated and cells were resuspended in 100 µl H2O. 
10 µl Glusulase (PerkinElmer) were added and incubated for 3.5–5 min at RT for en-
zymatic partial digestion of asci. The reaction was stopped by dilution with 500 µl 
H2O and incubation on ice. 20 µl cell suspension were added to the boundary area of 
a YPD plate (2.1.4, Table 14). Tetrads were dissected and spores positioned indivi-
dually on the plate using an MSM System (Singer Instruments) dissection micro-
scope. The plate was incubated for 3–5 days at 30 °C. 
2.2.2.5 Determination of the mating type of S. cerevisiae clones 
To test the mating type of yeast clones a colony PCR (2.2.2.3.4) was performed us-
ing three mating type specific primers (2.1.3, Table 10) together in one reaction. An 
amplified product of 404 bp or 544 bp indicates Mat α or Mat a, respectively, while a 
diploid clone can be identified by the amplification of both bands. 
2.2.2.6 Plasmid shuffling and viability test 
In yeast it is possible to easily replace one gene that is born on a plasmid by another 
by plasmid shuffling. Therefore the gene of interest was present on a plasmid con-
taining a URA3 selection marker gene (e.g. pRS316, 2.1.2, Table 7). A second plas-
mid with another selection marker (e.g. LEU2, pRS315, 2.1.2, Table 7) was trans-
formed into cells (2.2.2.2). Transformants containing both plasmids were selected by 
growth on SC -Leu, -Ura plates (2.1.4, Table 14). Cells were then grown on an 
SC -Leu plate (2.1.4, Table 14), selecting only for the second plasmid and eventually 
allowing loss of the plasmid containing the URA3 marker, then cells were grown on a 
YPD plate (2.1.4, Table 14). A pin-head size amount of cells from this plate was 
washed in 500 µl H2O. After centrifugation (15 s, 20,000 × g, RT) cells were resus-
pended in 500 µl H2O. Cell suspensions were vortexed immediately before all follow-
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ing pipetting steps. 50 µl cell suspension were diluted to 500 µl with H2O, thus creat-
ing five serial dilutions with a 1:10 ratio. 3 µl of each dilution were spotted on a 5-FOA 
plate and as control on a YPD plate (2.1.4, Table 14). Plates were incubated two 
days at 30 °C. Only cells that had lost the plasmid containing the URA3 marker gene 
can grow on a 5-FOA plate. Provided that this plasmid contained the only copy of an 
essential gene, cells growing on a 5-FOA plate were rescued by another copy pre-
sent on the second plasmid, while the first plasmid was lost. 
2.2.3 Agarose gel electrophoresis for DNA separation 
DNA was analysed by horizontal gel electrophoresis. Gels contained 1 % agarose 
dissolved in TBE and 1 × SYBR Safe DNA gel stain (2.1.5, Table 16) and were 
casted and run in PerfectBlue gel systems (Peqlab). 6 × DNA loading dye 
(2.1.5, Table 16) was added to DNA solutions and gels were run (2.1.5, Table 16) at 
15–20 V/cm using TBE as running buffer. DNA was visualised by ultraviolet transil-
lumination at a wavelength of 366 nm in a gel documentation system (Intas). 
2.2.4 Cell growth and purification of endogenous S. cerevisiae 
Pol II 
2.2.4.1 Fermentation of S. cerevisiae cells 
The respective S. cerevisiae Pol II purification strain (2.1.1, Table 4) was streaked on 
a YPD plate (2.1.4, Table 14) and incubated for three days at 30 °C. 50 ml YPD-
Amp-Tet (2.1.4, Table 14, Table 15) were inoculated with cells from the plate and 
incubated (10–15 h, 30 °C, shaking at 150 rpm). 500 ml YPD-Amp-Tet were inocu-
lated with 50 ml of the previous culture and incubated (10–15 h, 30 °C, shaking at 
150 rpm). 15–17 l YPD-Amp-Tet-antifoam C (pH 6.9, 2.1.4, Table 14, Table 15) were 
inoculated at an OD600 of 0.2–0.25 with the previous culture and incubated in a fer-
menter (Laborfermenter Typ NLF 30 L, Bioengineering) (10–18 h, 30 °C, stirring at 
250 rpm, air flow at 20 Nl/h). Typically 200 l YPD-Amp-Tet-antifoam C (pH 6.9) were 
inoculated at an OD600 of 0.2–0.25 with the previous culture and incubated in a fer-
menter (Pilot Fermenter Typ P 300 L, Bioengineering) (10–18 h, 30 °C, stirring at 
250 rpm, air flow at 82 Nl/h). Until beginning of 2009 yeast fermentation was carried 
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out in an analogous fashion using two other fermenters (ISF200 and ABEC, Infors). 
Cells were harvested at late log or early stationary phase. 
2.2.4.1.1 Harvesting of cells from 20 l fermenter 
After incubation in the 20 l fermenter cells were harvested by centrifugation (10 min, 
5,471 × g, 4 °C). 10–20 g of cells per litre cell culture were usually obtained. Cells 
were resuspended in 330 ml 3 × freezing buffer (2.1.5, Table 19) per kg of cells at 
4 °C. 200 ml aliquots of cell suspension containing ~150 g of cells were frozen in liq-
uid N2 and stored at -80 °C. 
2.2.4.1.2 Harvesting of cells from 200 l fermenter 
After incubation in the 200 l fermenter cells were harvested directly using a continu-
ous flow centrifuge (Z41/G, Carl Padberg Zentrifugenbau) (2 × 120 min, 
20,000 × rpm, 20–30 °C). 5–15 g of cells per litre cell culture were usually obtained. 
Cells were treated as described (2.2.4.1.1). 
2.2.4.2 Purification of Pol II via immunoaffinity chromatography 
Wild type Pol II not containing any affinity tags can be specifically purified via an im-
munoaffinity step (Edwards et al., 1990). This procedure was used to purify ten-
subunit Pol II (Table 1) from the rpb4 deletion strain CB010Δrpb4 (2.1.1, Table 4). 
2.2.4.2.1 Cell lysis 
3 × 200 ml cell suspension (2.2.4.1) were thawed in a water bath (T < 30 °C). All fol-
lowing steps were performed on ice or at 4 °C. 1 ml 100 × PI (2.1.5, Table 16) was 
added and the suspension transferred to the metal chamber of a BeadBeater (Bio-
Spec Products), containing 200 ml soda lime glass beads (Ø = 0.5 mm, BioSpec 
Products). Air bubbles were removed stirring gently with a glass rod. The chamber 
was completely filled up with HSB150 (2.1.5, Table 18) before assembly with the im-
peller and motor, which was run 60–70 min in cycles being 30 s on and 90 s off. To 
prevent warming, the lysis chamber was surrounded and covered with salt-ice mix, 
which was regularly renewed. The lysate was separated from beads filtering through 
a mesh funnel and washed with HSB150, not exceeding a total volume of 1000 ml. 
The lysate was centrifuged twice (45 min, 13,689 × g, 4 °C) and filtered through 
cheesecloth and paper filter to remove the lipid phase of the lysate. 
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2.2.4.2.2 Heparin affinity chromatography 
The following steps were performed at 4 °C. 250 ml Heparin Sepharose 6 Fast Flow 
(Amersham Biosciences, now GE Healthcare) affinity resin were equilibrated with 
three cv HSB150 (2.1.5, Table 18) using an Econo Pump (Bio-Rad). The lysate 
(2.2.4.2.1) was loaded, then washed with three cv HSB150 and eluted with two cv 
HSB600 (2.1.5, Table 18). The first 100 ml of elution were discarded; the following 
400 ml were collected. 
2.2.4.2.3 (NH4)2SO4 precipitation and redissolving 
291 g fine ground (NH4)2SO4 per litre were added to the elution fraction and incu-
bated overnight at 4 °C, stirring (80–150 rpm) for protein precipitation. The solution 
was centrifuged (45 min, 21,859 × g, 4 °C) and the precipitate was dissolved in 40 ml 
1 × TEZ0 (2.1.5, Table 18). If necessary 1 × TEZ0 was added to decrease conductiv-
ity, which was measured diluting 30 µl to 6 ml with deionised H2O (Millipore) using a 
Konduktometer (Schott) and should be < 400 µS/cm. Finally the solution was centri-
fuged (15 min, 34,155 × g, 4 °C) to remove undissolved particles. 
2.2.4.2.4 Immunoaffinity chromatography 
The immunoaffinity resin contained immobilised antibody 8WG16 (NeoClone) that 
binds selectively to the C-terminal domain of Rpb1 in its unphosphorylated state. Two 
columns with each 5 ml resin were equilibrated with three cv TEZ250 lacking DTT 
and PI followed by one cv TEZ250 (2.1.5, Table 18). The sample was loaded onto 
one column whose flow-through was directly loaded onto the second column. Col-
umns were closed, equilibrated 10 min at RT, washed with five cv TEZ500 and bound 
proteins were eluted with TEZ500-glycerol (2.1.5, Table 18). At least 15 1 ml fractions 
were collected and immediately transferred to ice. Protein content of fractions was 
qualitatively checked adding 10 µl sample to 200 µl of a 1:5 dilution of Bio-Rad Pro-
tein Assay dye reagent concentrate (Bio-Rad) in a microtitre plate and peak fractions 
were pooled. DTT was added ad 10 mM and the pool stored overnight at 4 °C. Im-
mediately after use, the antibody columns were washed with three cv TEZ500-
ethylene glycol, reequilibrated with three cv TEZ250-azide and stored at 4 °C in 
TEZ250-azide (2.1.5, Table 18). 
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2.2.4.2.5 Buffer exchange, (NH4)2SO4 precipitation and storage 
As Pol II was eluted from the immunoaffinity column with 50 % glycerol (2.2.4.2.4), 
buffer had to be exchanged prior to (NH4)2SO4-precipitation. The pooled sample was 
diluted to 50 ml with Pol II buffer and concentrated using an Amicon Ultra-15 Centri-
fugal Filter Device, 100,000 MWCO (1,300 × g, 4 °C). After concentrating to ~5 ml, 
~10 ml Pol II buffer were added and concentrated further. Alternately protein sample 
was added and concentrated. Pol II buffer was added repeating the concentration 
until the conductivity (2.2.4.2.3) of the flow through corresponded to the one of Pol II 
buffer. The sample was concentrated to 2 mg/ml protein concentration determined as 
described (2.2.6). For precipitation, 1.13 times the volume of (NH4)2SO4 solution (sa-
turated at RT) was added to aliquots of 100–500 µg purified Pol II. Samples were 
incubated 1–14 h at 4 °C on a rotating wheel and centrifuged (30 min, 16,060 × g, 
4 °C). The supernatant was partly removed, leaving a liquid-covered protein precipi-
tate. Samples were frozen in liquid N2 and stored at -80 °C. 
2.2.4.3 Purification of Pol II via Ni-NTA affinity chromatography 
2.2.4.3.1 Cell lysis 
Cell lysis was performed as described (2.2.4.2.1) with the following exceptions: Typi-
cally 2 × 200 ml cell suspension (2.2.4.1) were used per purification. Lysis in the 
BeadBeater was done for 80 min, the lysate was centrifuged once and filtering 
through cheesecloth was omitted. 
2.2.4.3.2 Ultracentrifugation, (NH4)2SO4 precipitation and redissolving 
The lysate was subjected to ultracentrifugation (90 min, 76,221 × g, 4 °C) using an 
SW28 rotor (Beckman-Coulter). The aqueous phase of the supernatant was col-
lected. 291 g fine ground (NH4)2SO4 per litre were added to the elution fraction and 
incubated overnight at 4 °C, stirring (80–150 rpm) for protein precipitation. The solu-
tion was centrifuged (2 × 45 min, 34,200 × g, 4 °C) and the precipitate was dissolved 
in 140 ml HSB0/0 (2.1.5, Table 19) per 100 g of (NH4)2SO4 pellet by stirring 1–2 h at 
4 °C. Conductivity (2.2.4.2.3) of the protein solution was reduced to the conductivity 
corresponding to HSB1000/7 (2.1.5, Table 19) by addition of HSB0/0. The sample 
was centrifuged (10 min, 34,200 × g, 4 °C) and imidazole was added ad 7 mM. 
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2.2.4.3.3 Ni-NTA affinity chromatography 
Ni-NTA Agarose (QIAGEN) was equilibrated with HSB1000/7 (2.1.5, Table 19) not 
containing DTT. The sample was mixed with 16 ml Ni-NTA Agarose and incubated 
for 60 min, stirring at 4 °C. The suspension was split into three aliquots and applied 
each to a gravity flow column. The resin was washed with five cv HSB1000/7 and 
then three cv Ni buffer7 (2.1.5, Table 19). When eluting hexahistidine-tagged Pol II, 
three cv each of Ni buffer50 and Ni buffer100 (2.1.5, Table 19) were applied to the 
column. When eluting decahistidine-tagged Pol II, three cv each of Ni buffer100 and 
Ni buffer200 (2.1.5, Table 19) were used. Elution fractions were pooled and conduc-
tivity was set cooresponding to MonoQ150 by addition of MonoQ0 (2.1.5, Table 19). 
2.2.4.3.4 Anion exchange chromatography 
The Ni-NTA affinity elution fraction was centrifuged (20 min, 17,211 × g, 4 °C). A 
Mono Q 10/100 GL (Amersham Biosciences, now GE Healthcare) was equilibrated 
with MonoQ150 using an ÄKTAexplorer HPLC system (Amersham Biosciences, now 
GE Healthcare), the sample was loaded and washed with four cv MonoQ150. For 
elution a linear salt gradient over twelve cv from MonoQ150 to MonoQ2000 
(2.1.5, Table 19) was applied. Pol II typically eluted at a conductivity of 50–55 mS/cm 
and the respective fractions were pooled. 
2.2.4.3.5 Buffer exchange, (NH4)2SO4 precipitation and storage 
After anion exchange chromatography the pooled sample was diluted and buffer was 
exchanged to Pol II buffer followed by (NH4)2SO4 precipitation and storage as de-
scribed (2.2.4.2.5). 
2.2.4.4 Small scale purification of Pol II for test purposes 
For a qualitative test Pol II purification was performed in a small scale as described 
(2.2.4.3) with changes described in the following. Cells were grown in a 2 l culture 
and harvested as described (2.2.4.1, 2.2.4.1.1). A 50 % (w/v) cell suspension con-
taining 10 g of cells was added to 20 ml soda lime glass beads (Ø = 0.5 mm, Bio-
Spec Products) subjected to cell lysis (3 × 4 min rotation at 500 rpm with 1 min 
pause, 4 °C) using a Pulverisette 6 classic line (Fritsch). During anion exchange a 
Mono Q 5/50 GL (Amersham Biosciences, now GE Healthcare) was used. 
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2.2.5 Expression and purification of Rpb4/7 
2.2.5.1 Recombinant expression of Rpb4/7 in E. coli 
The Rpb4/7 expression plasmid pET-21b(+)-Rpb4/7 (2.1.2, Table 5) was transformed 
(2.2.1.4.1) into BL21-CodonPlus (DE3)-RIL cells (2.1.1, Table 3) and incubated on an 
LB-Amp plate (2.1.4, Table 12, Table 13). 25 ml LB-Amp medium were inoculated 
with cells from the transformation plate and incubated for 6 h at 37 °C, shaking at 
180 rpm. Expression was performed in auto-inducing medium (Studier, 2005). 2 l ZY-
Amp (2.1.4, Table 12, Table 13) were inoculated with the 25 ml preculture and incu-
bated for 3.5 h at 37 °C, shaking at 180 rpm until OD600 reached 0.6–0.8. The tem-
perature of the cell culture was decreased quickly on ice and subsequently incubated 
for 24 h at 20 °C, shaking at 180 rpm. Cells were harvested by centrifugation (20–
30 min, 5,471 × g, 4 °C), resuspended in 25 ml Rpb4/7 freezing buffer 
(2.1.5, Table 20), frozen in liquid N2 and stored at -80 °C. 
2.2.5.2 Purification of Rpb4/7 
2.2.5.2.1 Cell lysis 
Cells from 8 l expression culture were pooled and lysed using a homogeniser (Emul-
siFlex-C5, Avestin). The lysate was cleared by centrifugation (2 × 30 min, 26,891 × g, 
4 °C). 
2.2.5.2.2 Ni-NTA affinity chromatography 
4 × 2 ml Ni-NTA Agarose (QIAGEN) were equilibrated with five cv buffer0 
(2.1.5, Table 20). All subsequent steps were carried out at 4 °C. The lysate was 
loaded twice by gravity flow. The resin was washed with five cv buffer0 then with 
three cv each of salt buffer, buffer10 and buffer20 (2.1.5, Table 20). Proteins were 
eluted applying three cv buffer50 and six cv buffer200 (2.1.5, Table 20). 
2.2.5.2.3 Anion exchange chromatography 
Ni-NTA elution fractions (2.2.5.2.2) were pooled and diluted slowly with SourceQ0 to 
the conductivity of SourceQ100 (2.1.5, Table 20). The sample was filtered using a 
Millex-GP, filter pore size 0.22 µm (Millipore). The following steps were performed 
using an FPLC system (ÄKTApurifier, Amersham Biosciences, now GE Healthcare). 
The anion exchange column (SOURCE 15Q 16/10, Amersham Biosciences, now GE 
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Healthcare) was equilibrated with a mixture of 5 % SourceQ2000 and 95 % Sour-
ceQ0 (2.1.5, Table 20). Ni-NTA elution fraction was loaded to the column and 
washed with two cv as before. Elution was performed with a linear salt gradient of 
100–1000 mM NaCl (5 %–50 % SourceQ2000) over ten cv. Rpb4/7 eluted at a con-
ductivity of 28–31 mS/cm.  
2.2.5.2.4 Size exclusion chromatography 
Rpb4/7 containing fractions after anion exchange chromatography (2.2.5.2.3) were 
pooled and concentrated using an Amicon-Ultra-15 Centrifugal Filer Unit, MWCO 
10 kDa (Millipore) to a volume of 5 ml. The protein solution was filtered as before 
(2.2.5.2.3) and subjected to size exclusion chromatography using a HiLoad 26/60 
Superdex 75 pg column (Amersham Biosciences, now GE Healthcare) with Pol II 
buffer (2.1.5, Table 20) as running buffer. Fractions of interest were pooled and con-
centrated as before to a concentration of 6 mg/ml. 40 µl aliquots corresponding to 
5 nmol Rpb4/7 were frozen in liquid N2 and stored at -80 °C. 
2.2.6 Measurement of protein concentration 
Protein concentration of protein solutions was determined according to the Bradford 
assay (Bradford, 1976). A 1:5 dilution of Bio-Rad Protein Assay dye reagent concen-
trate (Bio-Rad) was used to measure absorption at a wavelength of 595 nm in a 1 cm 
plastic cuvette with a BioPhotometer (Eppendorf). Standard absorption values were 
determined for each batch of reagent using bovine serum albumin (Albumin Fraktion 
V, Roth). 
2.2.7 Denaturing concentration of proteins by trichloroacetic acid 
precipitation 
To visualise proteins by SDS-PAGE from low concentrated protein solutions proteins 
were concentrated by precipitation with TCA. 6.1 N (= 100 %) TCA was added to the 
protein solution to a final concentration of 10 % (v/v) TCA. The sample was incubated 
30–60 min on ice or alternatively overnight at 4 °C and precipitated protein was pel-
leted by centrifugation (60 min, 16,100 × g, 4 °C). The pellet was washed with 1 ml 
acetone, which was equilibrated by incubation at -20 °C in advance. After centrifuga-
tion (5 min, 16,100 × g, 4 °C) the pellet was dried by incubating the open reaction 
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tube for 60 min at RT and dissolved in 6 µl 1 × SDS loading dye (2.1.5, Table 16). If 
an acidic pH was shown by the solution turning yellow, the solution was neutralised 
by bringing the surface in contact with the gas phase above a 25 % NH3-solution until 
the sample solution turned blue. 
2.2.8 SDS-PAGE for protein separation 
Electrophoretic separation of proteins was conducted by vertical SDS-PAGE. Gels 
contained 3.75 % (v/v) acrylamide and 15 % (v/v) acrylamide (Rotiphorese Gel 30 
(37.5:1), Roth) in the stacking and separating gel, respectively and 1 x stacking or 
separating gel buffer (2.1.5, Table 16) with 0.01 %–0.05 % TEMED and 0.1%–
0.065 % (w/v) APS. Gels were casted and run in Mini-gel systems (Bio-Rad) using 
Tris-glycine running buffer (2.1.5, Table 16). To achieve better protein separation 
acrylamide gradient gels (NuPAGE Novex 4–12 % Bis-Tris Gel 1.0 mm, Invitrogen) 
were run in a Novex Mini Cell (Invitrogen) using MES running buffer (2.1.5, Table 16). 
5 × SDS loading dye (2.1.5, Table 16) was added to samples and incubated for 5 min 
at 95 °C. Gels were stained in Coomassie stain for 20–60 min at RT and destained 
overnight at RT in destain (2.1.5, Table 16). 
2.2.9 X-ray crystallographic analysis of Pol II complexes 
2.2.9.1 Nucleic acid scaffold formation by annealing 
To form non-covalent nucleic acid complexes, DNA or RNA oligonucleotides (dis-
solved at 400 µM in TE (2.1.5, Table 22)) were mixed in equimolar amounts and di-
luted to 100 µM by addition of TE. Annealing was performed in a volume of 25–50 µl 
in a T3000 Thermocycler (Biometra). At 99 °C lid temperature the solution was 
heated for 180 s at 95 °C and temperature was subsequently reduced (90 s 
per -1 °C) to 20 °C. 
2.2.9.2 Protein-nucleic acid complex assembly and gel filtration 
Typically 500 µg (NH4)2SO4-precipitated Pol II (2.2.4.2, 2.2.4.3) were thawed while 
centrifuging (15–25 min, 16,060 × g, 4 °C). The precipitate was dissolved in 125 µl 
Pol II buffer per 100 µg Pol II and the concentration was determined (2.2.6). Typically 
a twofold molar excess of an annealed nucleic acid scaffold (2.2.9.1) was added and 
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incubated (10 min, 350 rpm, 20 °C) to assemble a Pol II-nucleic acid complex. Then 
Rpb4/7 (2.2.5.2) was added in a fivefold molar excess with respect to Pol II and the 
mixture was incubated (20 min, 350 rpm, 20 °C) for assembly. After centrifuging 
(10 min, 16,060 × g, 4 °C) stoichiometric complexes were purified by gel filtration in 
Pol II buffer (2.1.5, Table 21) using a Superose 6 10/300 GL and an ÄKTAexplorer 
HPLC system (Amersham Biosciences, now GE Healthcare). The solution was con-
centrated (4,656 × g, 4 °C) using an Ultrafree Centrifugal Filter Unit, 10,000 MWCO 
(Millipore) to a Pol II concentration of 4 mg/ml. Typically a twofold molar excess of the 
annealed nucleic acid scaffold (2.2.9.1) was added and  the sample was centrifuged 
(10 min, 16,060 × g, 4 °C) prior to crystallisation. 
2.2.9.3 Crystallisation setup, crystal harvesting and freezing 
Pol II-nucleic acid complexes were crystallised using the hanging drop method. 
500 µl mother solution (2.1.5, Table 21) were added to a reservoir of an EasyXtal 
Tool (QIAGEN). The drop contained 1.5–2.5 µl Pol II-nucleic acid complex sample 
and 1 µl of the reservoir solution. Crystallisation plates were incubated at 20 °C. 
Crystals formed after 5–7 days. Crystals were transferred to 200 µl mother solution at 
20 °C. The glycerol concentration was increased to 20 or 22 % (v/v) glycerol in five 
steps with 4 % or 4.4 % increments per hour by exchanging the solvent to a respec-
tive mixture of mother and cryo solution (2.1.5, Table 21). After 20 min the solvent 
was replaced by a solution of the last condition containing additionally 2–10 µM an-
nealed nucleic acid scaffold. Crystals were transferred to 8 °C in a polystyrene box 
and then incubated overnight at 8 °C. Crystals were then mounted to cryo loops, 
plunged into liquid N2 and kept at liquid N2 until taking measurements. 
2.2.9.4 X-ray diffraction measurement using synchrotron radiation 
Crystals were exposed to synchrotron radiation at the Swiss Light Source (SLS) at 
beamline X06SA. Crystals were cooled by a gaseous N2 cryo stream and exposed to 
6–11 × 1011 photons/s with wavelengths of 0.9–1.1 Å. Crystals were oscillated in 
0.25° increments and exposed 0.5–1.5 s per frame when recording data sets and X-
ray diffraction was detected with a MarMosaic 225 CCD (MarResearch) or a PILA-
TUS 6M pixel detector (DECTRIS). 
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2.2.9.5 Data processing, refinement and model building 
Recorded data sets were visualised, integrated and scaled using the HKL package 
(Otwinowski & Minor, 1997) or XDS (Kabsch, 1993). Initial phases were obtained by 
molecular replacement using the program Phaser of the CCP4 software suite 
(Potterton et al., 2003) using the complete 12-subunit Pol II (Armache et al., 2005) as 
search model. Rigid body refinement using three rigid groups for Pol II (clamp, core 
without clamp, Rpb4/7), refined phases and electron density maps were then calcu-
lated using CNS version 1.2 (Brünger et al., 1998). Manual model building and su-
perpositioning of structures was performed using O (Jones et al., 1991) or Coot 
(Emsley & Cowtan, 2004) by fitting the active-site aspartate loops. For initial model 
building initial Fo-Fc electron density maps were used. Refinement of atom coordi-
nates and B factors was performed with CNS version 1.2 and monitored with the free 
R factor excluding the same 2 % set of reflections from calculation as in refinement of 
the complete Pol II EC (Brueckner et al., 2007; Kettenberger et al., 2004). Figures 
were prepared with PyMOL (DeLano, 2002). 
2.2.10 In vitro-RNA elongation and cleavage experiments with Pol II 
2.2.10.1 Nucleic acid scaffold formation by annealing 
Nucleic acid complexes were formed by annealing as described (2.2.9.1). 
2.2.10.2 Protein-nucleic acid complex assembly 
(NH4)2SO4-precipitated Pol II (2.2.4.2, 2.2.4.3) was thawed as described (2.2.9.2). 
The precipitate was dissolved in TB (2.1.5, Table 22) to a final protein concentration 
of 0.5–1.4 µg/µl (corresponding to 1–3 µM Pol II). Remaining Pol II not used for as-
sembly was frozen in liquid N2 and stored at -80 °C until use, then thawed on ice and 
treated the same as freshly dissolved polymerase. For assembly, typically 2.5 pmol 
Pol II per reaction were mixed with annealed nucleic acid elongation construct 
(2.2.9.1, diluted to 5 µM in TB). The mixture was incubated (typically 20 min, 20 °C, 
shaking at 350 rpm) for assembly. 
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2.2.10.3 RNA elongation assay 
The in vitro product RNA elongation reaction was performed in TB in a volume of 
7.5–25 µl per reaction. Typically Pol II was assembled (2.2.10.2) with a twofold molar 
excess of nucleic acids. The reaction was started adding 1 mM of the substrate ribo-
nucleotides (2.1.5, Table 22). If not stated otherwise, the mixture was incubated 
(20 min, 28 °C) in a thermomixer for elongation. The reaction was stopped by addi-
tion of one reaction volume 2 × urea loading buffer (2.1.5, Table 22), incubation for 
5 min at 95 °C and immediate cooling on ice. 
2.2.10.4 RNA cleavage assays 
The in vitro RNA cleavage reaction was performed in TB in a volume of 7.5–25 µl per 
reaction. Typically a twofold molar excess of Pol II was assembled (2.2.10.2) with 
nucleic acids. The reaction was started adding equimolar amounts of TFIIS with re-
spect to Pol II and incubated (60 min, 28 °C) for cleavage. The reaction was stopped 
as described (2.2.10.3). 
2.2.10.5 Polyacrylamide gel electrophoresis for RNA separation 
To visualise RNAs after elongation or cleavage assays typically a fraction of the 
stopped reaction mixture (2.2.10.3, 2.2.10.4) containing one 1 pmol fluorescently la-
belled RNA was loaded onto a denaturing polyacrylamide gel (10–20 % acrylamide 
(nonfluorescent), 7 M urea (nonfluorescent), 1 × TBE (2.1.5, Table 22)). To cast and 
run gels either 1.0 mm cassettes and an XCell SureLock Mini-Cell (Invitrogen) or al-
ternatively a Sequi-Gen GT electrophoresis cell (Bio-Rad) was used. To heat gels, 
they were prerun using 1 × TBE as running buffer. The Mini-Cell was run 20–60 min 
at RT at 300–400 V and the Sequi-Gen GT cell at 40–50 W until a temperature of 
55–60 °C was reached. Samples were loaded and gels were run at the previous 
conditions for a time ensuring appropriate resolution depending on acrylamide con-
tent of the gel and RNA lengths to be separated. Mini gels were transferred to H2O, 
directly placed on the glass platen and immediately scanned using the Typhoon 9400 
Imager (Amersham Biosciences, now GE Healthcare).  From the Sequi-Gen GT cell 
the glass plate associated with the buffer chamber was removed and the gel covered 
with a plastic foil to avoid drying. The glass plate attached to the gel was positioned 
on the glass platen of the Typhoon Imager. FAM labelled RNAs were visualised by a 
fluorescence scan using the Typhoon 9400 Imager (excitation laser: blue (488 nm), 
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PMT voltage: 600–700 V, emission filter: 520 nm band-pass filter (520 BP 40), Pixel 
size: 50–100 µm, focal plane: platen or 3 mm for Mini-Gels or Sequencing gels, re-
spectively). 
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3 Results and discussion 
3.1 Molecular basis of RNA-dependent RNA polymerase II ac-
tivity 
3.1.1 Pol II and artificial minimal RNA–RNA elongation scaffolds 
3.1.1.1 Core Pol II can bind and elongate RNA according to template 
RNA in vitro 
Structural studies of the transcription EC revealed a B-form DNA duplex entering the 
downstream polymerase cleft, and a hybrid duplex of DNA template with RNA prod-
uct above the active site (Gnatt et al., 2001; Kettenberger et al., 2004; Westover et 
al., 2004) (Figure 3a). During RdRP activity, the hybrid site and the downstream cleft 
are expected to accommodate A-form RNA duplexes. The downstream cleft can ac-
commodate A-RNA, as observed for the 3’ stem of the RNA inhibitor FC* 
(Kettenberger et al., 2006) (Figure 3a). The FC* 3’ stem overlaps with two DNA tem-
plate positions downstream of the NTP-binding site (position +2, +3; Figure 3a), sug-
gesting that an RNA template could enter the active site in a similar manner to DNA. 
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Figure 3: RNA-dependent RNA polymerase II activity. 
a, Structure-based design of the RdRP scaffold. Structures of the complete Pol II EC
(Kettenberger et al., 2004) and the Pol II–FC* RNA inhibitor complex (Kettenberger et al.,
2006; Westover et al., 2004) were superimposed (2.2.9.5). The nucleic acids in the active
centre of the two complex structures (EC (Kettenberger et al., 2004) and FC* RNA
(Kettenberger et al., 2006)) are shown. The RdRP scaffold derived by combination of a
forked RNA template–product duplex with the 3’ stem of FC* RNA is shown at the bottom.
The RNA product strands are in red (transcription EC) or raspberry (RdRP EC), and the RNA
template strand is in orange. The FAM fluorescent label is shown as a green diamond. The
same colour code is used throughout. The 5’ stem of FC* RNA, which is not used here, is in
grey. The nucleotide addition site is denoted +1, and upstream and downstream positions
are depicted with negative and positive numbers, respectively. b, RNA synthesis by core
Pol II with the RdRP scaffold from a. Lane 1 shows the fluorescently labelled reactant RNA.
In lanes 2–10 the RNA scaffold (2.1.3, Table 9) was incubated with pure Pol II and different
types of NTP (2.2.10). Nucleotides incorporated by Pol II RdRP activity are shown as rasp-
berry open circles. UMP misincorporation at position +3 (lane 4) was confirmed by mass
spectrometry (Lehmann, 2006). 
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To test whether Pol II can indeed use an RNA template, we prepared an RNA scaf-
fold that combined the FC* 3’ stem with a putative RNA template–product duplex 
(RdRP scaffold; Figure 3a). To monitor potential RNA elongation, the product strand 
was labelled at the 5’ end with FAM. Incubation of this scaffold with core Pol II and 
NTPs led to RNA elongation (Figure 3b, lanes 1 and 2), indicating the formation of an 
active RdRP EC. Most RNA was elongated by eight nucleotides, but shorter and 
longer products were also observed. Mass spectroscopy of the products (Lehmann, 
2006) was consistent with RNA-templated synthesis (Table 25). Incubation of the 
RdRP EC with subsets of NTPs led to products that generally arose from templated 
nucleotide addition (Figure 3b, lanes 3–10), but the absence of the cognate NTP also 
permitted misincorporation. At position +1, AMP could be incorporated instead of 
GMP; at position +3, UMP could replace CMP. Misincorporation did not result from 
the use of RNA as a template, because a corresponding DNA template (scaffold 
DdRP; Figure 4a) produced the same product pattern (Figure 4c). These results 
show the intrinsic RdRP activity of Pol II.  
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Figure 4: Comparison of incorporation rate and misincorporation events during RNA
elongation with scaffolds RdRP and the corresponding scaffold DdRP that comprises
a DNA template strand. 
a, Scaffolds RdRP and DdRP (2.1.3, Table 8, Table 9) are depicted. The DNA template
strand is in blue. b, Time courses of RNA synthesis with the RdRP scaffold (lanes 2–5) and
the corresponding DNA template-containing scaffold DdRP (lanes 6–9). Lane 1 shows the
fluorescently labelled reactant RNA. c, RNA synthesis with scaffold RdRP (lane 1–10) and
DdRP (lane 11–20). Lane 1 and 11 show the fluorescently labelled reactant RNA. In lanes 2–
10 and 11–20, scaffolds were incubated with pure Pol II (2.2.10) and then incubated for 5 min
with different types and subsets of NTPs as indicated. Despite the faster rate of synthesis
with scaffold DdRP, the pattern of misincorporations is highly similar. 
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Table 25: Mass spectrometric analysis of RNA species observed after incubation of 
scaffold RdRP with Pol II and NTPs (compare Figure 3b). 
RNA product Incorporated nucleotides Theoretical mass12 Observed mass 
Reactant RNA - 5664 5663, 5665 
+1 G 6009 6009, 6010 
+2 GU 6315 631713 
+3 GUC 6620 661913, 662113 
+4 GUCA 6949 6949, 6951 
+5 GUCAA 7279 7279 
+6 GUCAAG 7624 7624 
+7 GUCAAGC 7929 7929 
+8  GUCAAGCU 8235 8235, 8236 
Template strand - 8342 8342 
   
                                                            
12 Calculated with Mongo Oligo Mass Calculator (Rozenski, 1999) and using a molecular weight for 
6-FAM of 537.5 Dalton. 
13 Observed after incubations with NTP subsets. 
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3.1.1.2 Position of RNA duplex bound to complete Pol II revealed in a 
crystal structure 
To unravel the structural basis of the RdRP activity, we determined the crystal struc-
ture of the complete Pol II bound to an RdRP scaffold. A scaffold with a 5’ extension 
of six nucleotides sufficed to form an active RdRP EC (Figure 5a, b), and enabled 
crystallographic analysis at 3.8 Å resolution to be made (Figure 6, Figure 7, Table 26 
and 2.2.9). The structure revealed the RNA template–product duplex in the site oc-
cupied by the DNA–RNA hybrid during transcription. The RNA product 3’ end was 
bound to the catalytic metal ion A (Figure 6). RNA synthesis occurred at the active 
site used during transcription, because product RNA was cleaved from the 3’ end by 
TFIIS (Figure 8), which stimulates RNA cleavage at the active site in the EC 
(Kettenberger et al., 2003), and in a Pol II–RNA complex (Johnson & Chamberlin, 
1994). For positions -1 to -5, the structure of the RNA duplex was essentially identical 
to that of the DNA–RNA hybrid (Kettenberger et al., 2004); however, at the upstream 
positions -6 to -9, changes in phosphate positions of up to 3 Å resulted in a de-
creased helical rise (Figure 6b). 
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Figure 5: Pol II RdRP activity on alternative artificial scaffolds. 
a, Alternative RdRP scaffolds. Nucleotides that are incorporated by Pol II RdRP activity are
shown as raspberry open circles. The stalling position is indicated. b-d, RNA synthesis with
alternative RdRP scaffolds shown in a. In lanes 2–6, alternative RNA scaffolds were incu-
bated with pure Pol II and NTPs (2.2.10). 
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Figure 6: Crystal structure of a Pol II–RdRP complex. 
a, Ribbon model of Pol II (grey) with an initial, unbiased difference Fourier electron-density
map (cyan, contoured at 2.2 σ).The map was calculated from protein model phases. It re-
veals the RNA template–product duplex of scaffold RdRP-ss6 (Figure 5a) in the active-centre
cleft of Pol II. The bridge helix is in green. The catalytic metal ion A is depicted as a magenta
sphere, and Zn2+ ions as cyan spheres. The view is related to that in Figure 3a by a 90° rota-
tion around a vertical axis. b, Comparison of the RNA template–product duplex in the RdRP
EC with the DNA–RNA hybrid duplex in the transcription EC (Kettenberger et al., 2004). Pro-
tein structures were superimposed as described (2.2.9.5). 
 
Figure 7: Electron density maps for the RNA template-product duplex in the Pol II
RdRP EC. 
a, Difference Fourier omit map obtained using phases from the final model with nucleic acids
removed. The view is as in Figure 6. The RNAs are shown as stick model. The Fo-Fc map at
2.2 σ is shown as green mesh. b, The final observed 2Fo-Fc electron density map calculated
with model phases is shown in blue with the contour level as indicated. Views are related by
a 90° rotation around a horizontal axis. 
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Table 26: Crystallographic data and refinement statistics for the Pol II complexes with 
the artificial scaffold RdRP-ss6 (Figure 5a and Figure 6) and the HDV-derived 6 bp 
stem-loop (Figure 12a). Data were collected, processed with program XDS (RdRP-ss6) 
or DENZO (HDV stem-loop) and refined as described (2.2.9). 
Pol II complex RdRP HDV 
Protein Data Bank accession 
code 
2R92 2R93 
Data collection 
Space group C2221 C2221 
Cell dimensions 
a, b, c (Å) 222.7, 393.8, 283.5 223.3, 394.9, 284.1 
Wavelength (Å) 1.0716 0.9999 
Resolution (Å) 50.0-3.8 (3.94-3.8)14 50.0-4.0 (4.14-4.0)14 
Rsym 0.077 (0.335) 0.149 (0.479) 
I/σI 21.4 (6.8) 12.4 (4.2) 
Completeness (%) 99.9 (100.0) 100.0 (99.9) 
Redundancy 8.5 (8.5) 8.5 (7.7) 
Refinement 
Resolution (Å) 50.0-3.8 50.0-4.0 
No. reflections 121,604 104,655 
Rwork/Rfree 0.212/0.246 0.216/0.241 
No. atoms 
Protein 31,207 31,207 
Nucleic acid 400 292 
Ligand/ion 9 9 
B-factors 
Protein 127.4 126.1 
Nucleic acid 195.3 166.4 
Ligand/ion 111.9 106.7 
R.m.s deviations 
Bond lengths (Å) 0.008 0.008 
Bond angles (°) 1.47 1.49 
  
                                                            
14 Highest resolution shell is shown in parenthesis. 
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3.1.2 Implications for HDV genome synthesis by Pol II 
3.1.2.1 Core Pol II can elongate HDV-derived scaffolds 
To investigate the physiological significance of the RdRP activity, we studied a termi-
nal segment of the HDV antigenome (Figure 10a). In cell extracts, this segment di-
rects RNA synthesis that is sensitive to the Pol II inhibitor α-amanitin (Filipovska & 
Konarska, 2000; Yamaguchi et al., 2001). The reaction involved RNA strand cleav-
age followed by elongation of the new 3’ end (Filipovska & Konarska, 2000; 
 
Figure 8: TFIIS-induced 3’ RNA cleavage in the RdRP EC (2.2.10.4). 
 
Figure 9: Scaffolds RdRP and DdRP (Figure 5a) compete for Pol II in RNA elongation
assays. 
Competition assays. Pol II and scaffold 1 were assembled as described (2.2.10.2). Scaffold 2
was added in relative amounts (1, 2, or 5-fold molar excess) with respect to scaffold 1 as
indicated, and incubated for 10 min at 20 °C. DdRP and RdRP scaffolds used as scaffolds 2
were identical to scaffolds 1 except that an 11mer product RNA was used, which lacked the
five 5’ residues and the fluorescent label (“cold” competitors). In control experiments (lanes 1
and 5) transcription buffer was added instead. The mixture was incubated with 1 mM NTPs
for 5 min at 28 °C. Without competing scaffold 2 the final product of each reaction is ob-
served (+8 in lane 1, +15 in lane 5), respectively. With increasing amounts of scaffold 2
(lanes 2-4 and 5-8), the final product of the reaction disappears and the reactant RNA re-
mains, indicating competition for Pol II. Competition is observed independent of the order of
scaffold addition. 
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Yamaguchi et al., 2001). The cleaved HDV segment apparently forms an RNA tem-
plate–product stem-loop and a downstream RNA duplex, which we shortened by re-
placing a natural bulge with a loop (HDV scaffold; Figure 10a). Incubation of this scaf-
fold with Pol II and NTPs resulted in RNA synthesis up to the end of the template, 
although synthesis also stopped prematurely (Figure 10b, lane 8). RNA synthesis 
was strictly dependent on the template. Only cognate NMPs were incorporated at 
positions +1 and +2 (Figure 10b, lanes 2–6). When UTP was omitted from the reac-
tion, RNA synthesis stopped at position +13 as expected (Figure 10b, lane 7). RNA 
synthesis was slow, but some final product appeared within 1 min (Figure 10c). 
These in vitro data match the evidence for Pol II-dependent HDV replication in vivo 
(Lai, 2005; Taylor, 2003), and argue for the physiological significance of the RdRP 
activity of Pol II. 
The higher processivity of Pol II on the HDV scaffold than on the RdRP scaffold may 
originate from the different upstream template–product duplex, which forms a stem-
loop instead of a forked end (Figure 11a). We therefore analysed two chimaeric scaf-
folds that recombine the upstream and downstream regions of the two scaffolds 
(Figure 11a). Combination of the RdRP upstream region with the HDV downstream 
region strongly decreased processivity compared with the HDV scaffold (Figure 11b). 
 
Figure 10: RNA synthesis with HDV RNA-derived scaffolds. 
a, Schematic representation of the terminal segment of the HDV antigenome (top) and the
HDV-derived scaffold (bottom). b, Pol II-dependent RNA synthesis with HDV scaffold. Lanes
2–8 show the elongation products after incubation with various subsets of NTPs as indicated.
c, Time courses of RNA synthesis with HDV scaffold. 
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In contrast, combination of the HDV upstream stem-loop with the RdRP downstream 
region enabled run-off synthesis that was not possible with scaffold RdRP (Figure 4a 
and Figure 11c). Thus, the HDV stem-loop promoted RdRP processivity. Consis-
tently, the stem-loop alone, containing only a two-nucleotide 5’ extension, formed a 
functional RdRP EC (Figure 12a). 
3.1.2.2 Pol II can cleave and elongate the HDV-terminal segment 
To test whether the RdRP-promoting stem-loop can be formed from the HDV terminal 
segment in vitro, we incubated the segment with pure Pol II–TFIIS complex. This re-
sulted in RNA cleavage at the internal bulge (Figure 13a, b). The bulge apparently 
connected the two RNA duplexes in a flexible way, to enable positioning of the scis-
sile RNA strand at the active site (Figure 13c). Cleavage produced a 6-bp stem-loop, 
comparing favourably with the 5-bp stem-loop that forms in extracts (Filipovska & 
Konarska, 2000). On the addition of NTP, the new 3’ end was elongated up to the 
end of the template (Figure 13a, b, lane 7). Consistently, a corresponding 6-bp stem-
loop with a 5’ extension supported RdRP activity (Figure 12a). Thus, the Pol II–TFIIS 
complex can cleave the HDV terminal segment and elongate the new 3’ end in vitro, 
which is consistent with models for HDV replication in vivo. 
 
Figure 11: RNA synthesis with chimaeric RdRP–HDV RNA-derived scaffolds. 
a, Design of two chimaeric scaffolds that recombine the upstream and downstream regions
of the artificial RdRP scaffold (Figure 4a) and the HDV-derived scaffold (Figure 10a). b-c,
Time courses of RNA synthesis with HDV and with the chimaeric scaffolds 1 (b) and 2 (c).
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3.1.2.3 Crystal structure of Pol II with an HDV-derived RNA stem-loop 
The 6-bp stem-loop that forms by HDV RNA cleavage in vitro (Figure 12a) could be 
structurally revealed in a complex with Pol II (Figure 12b, c, Table 26 and 2.2.9). The 
stem-loop bound the hybrid site, and phosphates at positions -1 to -5 occupied the 
same locations as in the artificial RdRP EC. However, RNA positions -6 and -7 had 
an increased helical rise (Figure 12c), showing that the hybrid site accommodates 
Figure 12: RNA synthesis and crystal structure of Pol II with an HDV-derived stem-
loop. 
a, HDV-derived terminal stem-loops consisting of 5 or 6 bp enable templated incorporation of
the next nucleotide(s). b, Difference electron density omit map for the 6-bp HDV stem-loop
bound to the hybrid site of complete Pol II (calculated with protein phases only, contoured at
3.0 σ). The disordered loop is indicated with a dashed line. The view is as in Figure 6a. c,
Superposition of the RNA template–product duplex in the HDV EC and the RdRP EC
(Figure 6) on the DNA–RNA hybrid duplex in the transcription EC (Kettenberger et al., 2004).
 
Figure 13: Mechanism of HDV replication initiation. 
a, Scaffold based on HDV antigenome before cleavage. b, Pure Pol II–TFIIS complex
cleaves the HDV antigenome terminal segment (a) and elongates the newly formed 3’ end on
the addition of NTP. For cleavage, Pol II–scaffold complex (625 nM) was incubated with
TFIIS (1.25 µM) in transcription buffer for 60 min at 28 °C. For elongation of the cleavage
product, the reaction mixture was incubated with 1 mM NTPs at 28 °C for 20 min. For lane 5,
the cleavage reaction was stopped after 60 min (‘Stop’). c, Model of initial interaction of the
HDV antigenome terminal segment with the Pol II–TFIIS complex. The stem-loop is placed in
accordance with the crystal structure (Figure 12b, c) and the downstream duplex in accor-
dance with the location of the FC* RNA 3’ stem. We predict that the HDV bulge passes the
bridge helix and active site, where cleavage occurs. 
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various RNA duplexes with upstream ends of different structure. The RNA loop was 
mobile except for one cytidine residue (Figure 12a, b). Consistently, a double muta-
tion in the loop did not impair activity (Figure 14). Because base-specific Pol II–RNA 
contacts are absent in both RdRP EC structures, Pol II recognizes the A-RNA stem 
rather than a particular RNA sequence. 
3.1.2.4 Length of elongatable upstream stem-loop is limited 
During transcription, upstream template and product strands are separated, whereas 
the HDV stem-loop probably persists during elongation. Consistently, Pol II readily 
used stem-loops with 5, 6, 7 or 10 bp as substrates, but not stem-loops with 13, 15 or 
18 bp (Figure 12a and Figure 15). Modelling revealed a clash of the polymerase lid 
with the RNA stem-loop when it reached a length of 10 or 11 bp (Figure 24). The 
 
Figure 15: HDV-derived stem-loops of different lengths serve as RdRP scaffolds. 
 
Figure 14: Mutational analysis of the loop in the HDV-derived scaffold. 
a, RNA scaffolds HDV and HDV-AG, which contains a CU to AG sequence alteration in the
terminal loop. b, Comparison of RNA elongation products obtained with RNA scaffolds
shown in a. Lanes 2 and 4 show elongation products. There are no significant differences in
the pattern of elongation products. 
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clash may destabilize the RdRP EC and facilitate stalling. This model explains why 
elongation with the HDV scaffold partly stalled when the stem-loop reached 13–18 bp 
(Figure 10a, b), and why replacement of the uracil at the downstream position +8 did 
not influence stalling (Figure 16). The model also explains stalling of the artificial 
RdRP ECs when a persistent template–product duplex would reach a length of 16 bp 
(Figure 3b and Figure 5). Similarly, a persistent DNA–RNA hybrid stalls the transcrip-
tion EC (Kireeva et al., 2000a; Naryshkina et al., 2006; Toulokhonov & Landick, 
2006). However, 12-subunit Pol II elongates an RNA scaffold containing a bulge in 
the stem (Figure 17a) until run-off (+10, Figure 17b). The bulge at positions -10 to -13 
was designed at the position probably clashing with the lid loop (Figure 24). Upon 
addition of nucleotide subsets misincorporation products were weakly observed when 
the cognate NTP was missing (Figure 17c, lanes 2, 4 and 6). Incorporation of cog-
nate NPTs was highly efficient (Figure 17c, lanes 3, 5 and 7), confirming the secon-
dary structure formation of the RNA as designed (Figure 17a). The limited RdRP 
processivity in vitro is apparently overcome during HDV replication in vivo by binding 
of the HDV-encoded elongation-stimulatory delta antigen to the polymerase clamp 
(Filipovska & Konarska, 2000; Yamaguchi et al., 2001; Yamaguchi et al., 2007). 
Clamp movements and/or RNA repositioning would enable the exit of a persistent 
stem-loop from the cleft. 
   
 
Figure 16: RNA synthesis with an HDV scaffold with U in position 18 mutated to C. 
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3.1.3 RdRP activity of Pol II remained unrecognised upon previous 
observations 
Our results also explain the previously observed apparently non-templated RNA 
elongation in a Pol II–RNA complex (Johnson & Chamberlin, 1994). The RNA used 
for these studies bound Pol II and was cleaved on the addition of TFIIS; cleavage 
products were elongated by a few nucleotides (Johnson & Chamberlin, 1994). We 
predict that this RNA formed an 11-bp stem-loop in the hybrid site, and a bulge or a 
3’ tail at the active site (Figure 18). TFIIS-stimulated cleavage then created a new 3’ 
end at the active site, which was elongated in a templated manner, until a critical 
template-product length was reached. Consistently, an 11-bp stem-loop resembling a 
cleaved species (Johnson & Chamberlin, 1994) supported templated nucleotide in-
corporation (Figure 18). Our results also explain previously observed cleavage and 
limited re-extension of a short RNA stem-loop by bacterial RNA polymerase (Kashlev 
Figure 17: RNA synthesis with an HDV RNA-derived bulge-containing stem-loop. 
a, Schematic representation of the HDV-derived 18 bp stem-loop and corresponding scaffold
containing a bulge and more templating bases. b, Pol II-dependent RNA elongation assay
with HDV-18-bp stem and HDV-bulge depicted in (a). Lanes 1 and 3 show the fluorescently
labelled reactant RNAs. Lanes 2 and 4 show the reaction products after incubation with
NTPs. Only the bulged scaffold can be elongated by Pol II. c, Pol II-dependent RNA synthe-
sis with HDV-bulge. Lanes 2–8 show the elongation products after incubation with various
subsets of NTPs as indicated. 
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& Komissarova, 2002). Thus, earlier observations (Johnson & Chamberlin, 1994; 
Kashlev & Komissarova, 2002) are apparently examples of the RdRP mechanism 
described here. 
3.1.4 Evolutionary progress of RNA polymerase activity from RNA 
to DNA templates 
The RdRP activity of Pol II provides a missing link in molecular evolution, because it 
supports the prediction that an ancestor of Pol II was the enzyme that replicated early 
RNA genomes (Poole & Logan, 2005). This is supported by the recent findings that 
the related bacterial RNA polymerase supports not only RNA synthesis with the non-
coding 6S RNA as template (Gildehaus et al., 2007; Wassarman & Saecker, 2006) 
but also RNA-facilitated RNA cleavage (Zenkin et al., 2006). The early RNA replicase 
apparently evolved to accept DNA as a template during the transition from RNA to 
DNA genomes. The early replicase was apparently a common ancestor also of dis-
 
Figure 18: Templated RNA elongation of an 11 bp stem-loop derived from pCPG79
RNA used in previous studies (Armache et al., 2005; Johnson & Chamberlin, 1994). 
a, Mfold (Zuker, 2003) secondary structure prediction of pCPG79 RNA. Cleavage sites ob-
served previously by TFIIS-induced cleavage (Johnson & Chamberlin, 1994) are indicated. b,
RNA scaffold derived from the predicted pCPG79 RNA structure in a. The scaffold corre-
sponds to the product obtained after the previously observed RNA cleavage at the central
cleavage site (Johnson & Chamberlin, 1994). The scaffold consists of the 3’ stem-loop of
pCPG79 RNA with an 11 bp stem and a two-nucleotide 5’-overhang. c, RNA elongation as-
say with the scaffold shown in b. Reactions were incubated with different NTPs or subsets of
NTPs for the time indicated (lanes 2–10). Only CTP leads to addition, indicating GMP-
templated RdRP activity. 
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tinct single-subunit RdRP enzymes, because these show a Pol II-like core protein 
fold and active site (Salgado et al., 2006). It is possible that the ancient RdRP activity 
of Pol II, which still replicates HDV, is still used in certain cellular processes, because 
many organisms lack dedicated single-subunit RdRPs. Given the slow nature and the 
impaired processivity of the RdRP activity in vitro, such processes would require 
stimulating factors or would be restricted to the generation of smaller RNAs. 
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3.2 Plasmid-based mutagenesis of Rpb1 in S. cerevisiae 
3.2.1 Strategy to create yeast strains for Rpb1 mutagenesis 
To study mutants of Rpb1, which is an essential protein, we chose to establish a 
plasmid-based mutagenesis system in S. cerevisiae (Figure 19). The advantage of 
such a system is that the target gene to be mutated is located on a plasmid and mu-
tations are not introduced in the genome. This enables easy identification of muta-
tions that render the protein non-functional und thus yeast cells non-viable. Therefore 
a strain is needed that carries a genomic knock-out of RPB1 but instead contains the 
gene on a rescue plasmid, which allows for plasmid shuffling: after transformation of 
a second plasmid containing the RPB1 mutant gene of interest, the rescue plasmid 
can be counter selected via its URA3 marker gene. Cells that do not contain URA3 
are positively selected on 5-FOA containing medium. The enzyme encoded by URA3 
enables cells to convert 5-FOA to 5-fluorouracil, which inhibits cell growth (Boeke et 
al., 1984). Only if the Rpb1 mutant is not lethal to the cells, then growth on 5-FOA 
containing medium occurs (Figure 23). The haploid Δrpb1 knock out strain with res-
cue plasmid can be obtained by sporulation of a rescue-plasmid containing diploid 
strain with one RPB1 allele knocked-out. 
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Figure 19: Creation of an Rpb1 mutagenesis strain. 
Creation of BJ5464 Δrpb1 pRS316-Rpb1 is shown schematically.
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3.2.2 Setup of plasmid shuffle strains 
The system of Rpb1 mutagenesis was designed such that it would be possible to per-
form both in vitro and in vivo studies. For in vitro studies with purified Pol II a plasmid 
shuffling strain was created based on the established Pol II purification strain BJ5464 
Rpb3 His-Bio (2.1.1, Table 4 and Figure 19). For in vivo analyses like chromatin im-
munoprecipitation studies a strain was created with a background corresponding to 
BY4741 or BY4742 (2.1.1, Table 4). 
3.2.2.1 Rpb1 knock-out in diploid strains 
The kanMX6 cassette was amplified (2.2.1.1) from pFA6a-kanMX6 (2.1.2, Table 6) 
using the oligonucleotides 3_Sc_Rpb1_20bp_up_KanMX6_5’_f and 
4_Sc_KanMX6_3’_Rpb1_20bp_down_r (2.1.3, Table 10) as PCR primers. Flanking 
regions 310 bp upstream and 232 bp downstream of the RPB1 ORF were amplified 
using 1_Sc_Rpb1_310bp_up_f with 2_Sc_Rpb1_20bp_up_KanMX6_5’_r and 
5_Sc_KanMX6_3’_Rpb1_20bp_down_f with 6_Sc_Rpb1_232bp_down_r 
(2.1.3, Table 10), respectively using genomic DNA of each BJ5626 and BY4743 as 
template. Genomic DNA was kindly provided by Heidi Feldmann. A knock-out frag-
ment containing upstream and downstream flanking regions of RPB1 upstream and 
downstream of the kanMX6-cassette, respectively, was generated in a hybridisation 
PCR (2.2.1.1) using the three previously amplified fragments as templates with prim-
ers 1_Sc_Rpb1_310bp_up_f and 6_Sc_Rpb1_232bp_down_r. The flanking regions 
direct the locus of insertion of the cassette by homologous recombination into the 
yeast genome. 
In the diploid strains BJ5626 and BY4743 (2.1.1, Table 4) one allele’s open reading 
frame of RPB1 was replaced by the kanMX6 cassette. In case of BJ5626 transforma-
tion of DNA for homologous recombination was done by electroporation (2.2.2.3.2.2), 
which did not work for BY4743, therefore chemical transformation (2.2.2.3.2.1) was 
applied resulting in strains BJ5626 Δrpb1/+ and BY4743 Δrpb1/+ (2.1.1, Table 4 and 
Figure 19). 
3.2.2.2 Cloning of an Rpb1 rescue plasmid 
For construction of the rescue plasmid pRS316-Rpb1 (2.1.2, Table 7) the RPB1 ORF 
with 523 bp upstream and 281 bp downstream flanking regions from genomic DNA of 
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BJ5626 and BY4743 was amplified (2.2.1.1) using 7_Sc_Rpb1_500bp_up_XhoI_f 
with 12_Sc_Rpb1_260bp_down_SacI_r as PCR primers (2.1.3, Table 10). The frag-
ment was inserted into pRS316 at the XhoI and SacI restriction sites. pRS316 has a 
low copy number in yeast cells. 
3.2.2.3 Cloning of a Pep4 and Prb1 rescue plasmid for sporulation 
BJ5626 Δrpb1/+ pRS316-Rpb1 and BY4743 Δrpb1/+ pRS316-Rpb1 (2.1.1, Table 4) 
were obtained upon transformation (2.2.2.2) of pRS316-Rpb1 into BJ5626 Δrpb1/+ 
and BY4743 Δrpb1/+. As BJ5626 Δrpb1/+ pRS316-Rpb1 was incompetent to 
sporulate due to the disruption of the protease genes PEP4 and PRB1 (Zubenko & 
Jones, 1981) the protease rescue plasmid pRS31N-Pep4-Prb1 (2.1.2, Table 7) was 
transformed into the strain (Figure 19). PEP4 and PRB1 were amplified using ge-
nomic DNA of BY4743 as template with 500 bp upstream and 195 bp or 200 bp 
downstream, respectively using Sc_Pep4_500bp_up_BamHI_f with 
Sc_Pep4_200bp_down_XhoI_r or Sc_Prb1_500bp_up_NotI_f with 
Sc_Prb1_200bp_down_BamHI_r, respectively as PCR primers (2.1.3, Table 10). The 
natNT2 cassette was amplified from pFA6a-natNT2 (2.1.2, Table 6) using 
pFA6a_S1_NdeI_f with pFA6a_S2_NsiI_r as PCR primers (2.1.3, Table 10). PEP4 
was inserted into pRS316 (2.1.2, Table 7) between the BamHI and XhoI restriction 
sites, then PRB1 was inserted between the NotI and BamHI restriction site. Then the 
URA3 marker gene within the pRS316 backbone was removed, inserting the natNT2 
cassette between the NdeI and NsiI restriction sites. Thus pRS31N-Pep4-Prb1 con-
tains genes for the proteases Pep4 and Prb1 and carries a clonNAT resistance 
marker replacing the URA3 prototrophy marker gene of pRS316. 
3.2.2.4 Sporulation to obtain haploid Rpb1 mutagenesis strains 
BJ5626 Δrpb1/+ pRS316-Rpb1 pRS31N-Pep4-Prb1 and BY4743 Δrpb1/+ pRS316-
Rpb1 were subjected to sporulation and dissected (2.2.2.4) and clones with the de-
sired selection markers were selected to obtain haploid strains corresponding to 
BJ5464 Δrpb1 pRS316-Rpb1 and BY4741 Δrpb1 pRS316-Rpb1 (2.1.1, Table 4). 
These strains contain the RPB1 gene on a plasmid with a URA3 marker and can thus 
be used for plasmid shuffling with 5-FOA (2.2.2.6) after transformation of another 
(e.g. mutant) copy of RPB1 on a second plasmid with a different marker (Figure 23). 
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3.2.3 Establishment of a His10-tag at Rpb1 
3.2.3.1 Cloning of N- and C-terminal His10-tag at Rpb1 on a plasmid 
A possibility to purify Pol II complexes containing mutant Rpb1 even in the presence 
of wild type Rpb1 was desired. Therefore a His10 affinity tag was introduced at Rpb1. 
Both an N- and C-terminal tag were created, with the N-terminal tag containing a 
penta(serinylalanine) linker to increase accessibility of the tag during affinity chroma-
tography. The tags were introduced by site-directed mutagenesis using 
7_Sc_Rpb1_500bp_up_XhoI_f with Sc_Rpb1_N-term-H10AS5_r and Sc_Rpb1_N-
term-H10AS5_f with 8_Sc_Rpb1-EagI_down_BamHI_r and 11_Sc_Rpb1-BspHI_up_f 
with Sc_Rpb1_C-term-H10_r and Sc_Rpb1_C-term-H10_f with 
12_Sc_Rpb1_260bp_down_SacI_r (2.1.3, Table 10) for the first PCR step (2.2.1.1) 
for the N- and C-terminal tags respectively using pRS316-Rpb1 as template. The two 
respective fragments were used as templates in a second PCR step using 
7_Sc_Rpb1_500bp_up_XhoI_f with 8_Sc_Rpb1-EagI_down_BamHI_r and 
11_Sc_Rpb1-BspHI_up_f with 12_Sc_Rpb1_260bp_down_SacI_r for the N- and C-
terminal fragments, respectively. Fragments were then inserted between the XhoI 
and EagI or BsiWI and SacI restriction sites of pRS315-Rpb1, to create pRS315-
Rpb1-N-H10 and pRS315-Rpb1-C-H10 (2.1.2, Table 7), respectively. 
3.2.3.2 Influence on cell growth of N- and C-terminally tagged Rpb1 
The His10-tag at Rpb1 should not induce structural changes in Rpb1 that could influ-
ence Pol II activity, which might have an effect of yeast growth. Therefore pRS315-
Figure 20: N- or C-terminal His10-tag do not influence yeast growth. 
Serial dilutions of yeast cells on a YPD plate (left) and a 5-FOA plate (right). 
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Rpb1-N-H10 and pRS315-Rpb1-C-H10 were transformed (2.2.2.2) into 
BJ5464 Δrpb1 pRS316-Rpb1 (2.1.1, Table 4). To shuffle plasmids (2.2.2.6) contain-
ing His-tagged Rpb1 serial dilutions of yeast cell suspensions were spotted on a YPD 
and 5-FOA plate (2.1.4, Table 14). Comparing growth of BJ5464 Δrpb1 pRS316-
Rpb1 with BJ5464 on the YPD plate, the strain containing the only copy of RBP1 on 
a plasmid grows slightly slower than the corresponding wild type strain BJ5464 
(Figure 20). Strains containing plasmid-encoded Rpb1 with a His-tag show the same 
growth as the control strains without His-tag both on the YPD and the 5-FOA plate. 
On the 5-FOA plate after loss of pRS316-Rpb1 no growth difference was observed 
between strains containing N- or C-terminally His-tagged Rpb1. Considering cell 
growth that is not influenced by the presence and position of the His-tag at Rpb1 both 
terminal His-tags are equally applicable. 
3.2.3.3 Suitability of His-tags for purification via affinity chromatography 
To test whether the N- and C-terminal His-tags at Rpb1 are suitable for Pol II purifica-
tion comprising a Ni-NTA affinity chromatography step, purifications in small scale 
were performed (2.2.4.4). At the anion exchange step Pol II eluted at a conductivity of 
50–60 mS/cm, which is typical also for Rpb3-tagged polymerase. Quantity and qual-
 
Figure 21: N- and C-terminal His10-tag lead to equal purification results. 
15 % SDS-PAGE (2.2.8) of the anion exchange elution fractions of Pol II purifications using
N- and C-terminal His-tags. M: Marker. 
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ity of Pol II obtained in this test purification were comparable for both variants 
(Figure 21). Thus in terms of purification yield and purity both terminal His-tags at 
Rpb1 are equally useful. 
3.2.3.4 Favouritism of the C-terminal His-tag at Rpb1 
Neither the N- nor C-terminal His-tag at Rpb1 interfered with growth of yeast (3.2.3.2) 
nor did they show significant differences for Pol II purification suitability (3.2.3.3). Po-
tential C-terminal degradation of Rpb1 is likely to result in loss of both the C-terminal 
His-tag and the CTD. Therefore using the C-terminal His-tag ensures that the CTD is 
entirely intact at the Ni-affinity step during the purification and hence the C-terminal 
His-tag was preferred to the N-terminal His-tag. 
3.2.4 Mutagenesis studies of Rpb1 
3.2.4.1 Strategy of plasmid-based mutagenesis 
Mutagenesis of RPB1 was performed using a plasmid-based technique. To create 
the mutagenesis template pRS315-Rpb1-C-H10 (2.1.2, Table 7), RPB1 with flanking 
regions was cut out of pRS316-Rpb1 at the XhoI and SacI restriction sites and sub-
 
Figure 22: pRS315-Rpb1-C-H10 as basis for mutagenesis. 
pRS315-Rpb1-C-H10 is depicted with the insert Rpb1-C-H10 with flanking regions (green) and
the yeast and E. coli replicative elements CEN6/ARSH4 and ColE1 (white), respectively and
selection markers LEU2 and AmpR (yellow), respectively. Single cutter restriction enzymes
with recognition sites in and around the RPB1 gene are labelled in blue. 
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cloned into pRS315 at the same sites to obtain pRS315-Rpb1. The His-tag was in-
troduced as described (3.2.3.1). 
   
 
Figure 23: Creation of Rpb1 mutant strains. 
Creation of strains containing Rpb1 mutant genes on a plasmid is depicted schematically. 
Results and discussion – Plasmid-based mutagenesis of Rpb1 in S. cerevisiae 75 
 
To introduce a mutation in the RPB1 gene only a part of the gene was amplified. De-
pending on the location of the desired mutation a fragment between two of the single 
cutter restriction sites (XhoI, AvrII, EagI, XbaI, BsiWI and SacI) in the RPB1 coding 
region in pRS315-Rpb1-C-H10 (Figure 22) was amplified introducing the mutation. In 
a first PCR step (2.2.1.1) the regions 5’ and 3’ of the mutation site were amplified 
separately, using an outer primer outside of the respective restriction enzyme recog-
nition site with a primer containing the desired mutation. The fragments were com-
bined in a second PCR step using only the outer primers to amplify the whole frag-
ment. The fragment containing the mutation was then inserted between the respec-
tive restriction sites in pRS315-Rpb1-C-H10 (2.1.2, Table 7) to obtain a plasmid en-
coding mutated and C-terminally His-tagged Rpb1 (Figure 23). 
3.2.4.2 Example of a mutation lethal to yeast: Pol II enzymes bearing a 
lid deletion could not be purified 
The lid loop of Pol II plays a role in separation of upstream template DNA and prod-
uct RNA (1.2.2). Preformed RNA stem-loops with stems longer than 13 bp were not 
elongated by Pol II in previously described RNA elongation experiments (3.1.2.4, 
Figure 15) as the RNA probably cannot fit into the hybrid-binding region due to an 
 
Figure 24: Upstream clash of the lid loop with a modelled HDV RNA duplex. 
A rigid 24 bp duplex A-RNA was modelled into the Pol II elongation complex by superposi-
tioning of terminal four base pairs with base pairs -1 to -4 in the HDV elongation complex
structure (Figure 12b, c, Table 26). The view is from the front (a) and along the helix axis
towards the Pol II active site (b). HDV product and template strand are shown in raspberry
and orange, respectively. Product and template strand of the RNA model are shown in dark-
salmon and lightorange, respectively. The lid loop with side chain stick models is shown in
yellow. 
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upstream clash with the lid loop (Figure 24). To investigate this idea further Pol II en-
zyme lacking the lid loop was desired for RNA elongation experiments. In 
S. cerevisiae the lid loop comprises residues 248–260 of Rpb1 which are flanked by 
α-helices (Cramer et al., 2001) (Figure 25). Lid deletion variants within RNA poly-
merases of other organisms were subjects of previous studies such as a deletion in 
E. coli RNA polymerase corresponding to residues 248–261 in Rpb1 (Toulokhonov & 
Landick, 2006) or P. furiosus RNA polymerase that was reconstituted from recombi-
nantly expressed subunits lacking residues 248–260 of Rpb1 (Naji et al., 2008). 
Deletion of residues 248–260 in Rpb1 leads to direct connection of the terminal resi-
dues of the adjacent α-helices (Figure 25) which might influence the secondary struc-
ture of these regions and thus have secondary effects on Pol II function. Therefore 
two plasmid variants comprising a deletion of residues 248–260 (pRS315-Rpb1-
Δlid1-C-H10, 2.1.2, Table 7) and of residues 249–259 (pRS315-Rpb1-Δlid2-C-
 
Figure 25: Pol II lid loop and adjacent region. 
The lid loop and N- and C-terminal neighbouring regions are depicted in yellow, green and
orange, respectively. Important residues are labelled.
Figure 26: Lid deletion is lethal in S. cerevisiae. 
Serial dilutions of yeast cells on a YPD plate (left) and a 5-FOA plate (right). Two representa-
tive clones each of both lid deletion variants (Δlid1 and Δlid2) cannot grow on a 5-FOA plate.
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H10, 2.1.2, Table 7) that should not induce undesired effects on secondary structures 
were cloned as described (3.2.4.1). After plasmid shuffling on a 5-FOA-containing 
plate (2.2.2.6) both lid deletion variants showed a lethal phenotype (Figure 26) con-
firming an essential role of the Pol II lid loop. Thus to cultivate cells containing a lid 
deletion variant a rescue copy of wild type RPB1 is required. The His-tag at the mu-
tated copy of Rpb1 allows for selective purification of polymerases containing mu-
tated proteins, while polymerases containing a wild type copy without tag should be 
separated. 
A strain containing the Δlid2 variant and a wild type copy of RPB1 (BJ5464 Δrpb1 
pRS316-Rpb1 pRS315-Rpb1-Δlid2-C-H10, 2.1.1, Table 4) was cultivated by fermen-
tation (2.2.4.1 and 2.2.4.1.1) in SC -Leu medium (2.1.4, Table 14) selective for the 
plasmid encoding the Δlid2 gene and a purification of Pol II (2.2.4.3) was conducted. 
Unfortunately Pol II could not be obtained in sufficient amounts for any further stud-
ies. The anion exchange chromatogram of the Pol II-Δlid2 purification is generally 
comparable to a typical wild type Pol II purification chromatogram but the Pol II peak 
is missing (Figure 27). Cells containing an additional wild type copy of Rpb1 are func-
tionally not dependent on the mutated version of the protein. As Pol II-Δlid2 is not 
sufficient for yeast cell viability (Figure 26) it is probably non-functional in vivo in at 
least one step of transcription. 
 
Figure 27: Pol II-Δlid2 could not be isolated by protein purification. 
Overlay of anion exchange chromatograms of the last purification step of Pol II-Δlid2 and a
representative wild type Pol II purification. Relative absorptions at 280 nm and 260 nm, con-
ductivity and salt in the running buffer are shown as indicated by the colour code. Curves for
Pol II-Δlid2 and wild type Pol II are depicted as solid and dashed lines, respectively. The po-
sition of the peak containing Pol II is indicated. 
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When Pol II encounters DNA damages and cannot transcribe further, Rpb1 is ubiq-
uitylated as a first step in transcription-coupled DNA repair (Bregman et al., 1996) 
and subsequently subjected to proteasomal degradation (Beaudenon et al., 1999; 
Ratner et al., 1998). Specifically Rpb1 but not the whole Pol II complex is degraded 
upon DNA damage-inducing UV irradiation (Chen et al., 2007). Ubiquitylation of Pol II 
does not only occur for polymerases stalled at DNA damage sites but also upon tran-
scriptional arrest independent of DNA damages (Somesh et al., 2005). 
As the lid deletion in Pol II is a structurally minor change, a normal assembly and pre-
initiation complex formation behaviour can be assumed for Pol II-Δlid2 in vivo. The 
essential role of the lid probably makes an appearance during the processes of tran-
scription initiation or elongation. Thus lid-truncated Pol II might be arrested on DNA 
with Rpb1-Δlid2 being a subject for degradation. In turn this specific degradation 
might prevent successful purification of Pol II-Δlid2. A possibility to counteract degra-
dation of Rpb1 is overexpression in yeast that can be induced by removal or addition 
of antibiotics (Garí et al., 1997). A tetracycline-inducible promoter was amplified from 
pCM251 (2.1.2, Table 6) and inserted upstream of Rpb1-Δlid2 to create pRS315-Tet-
Rpb1-Δlid2-C-H10 (2.1.2, Table 7), which encodes Rpb1-Δlid2 under control of the 
inducible promoter. Preliminary experiments expressing Rpb1-Δlid2 from this plasmid 
did not indicate phenotypes suggestive of a successful overexpression and stable 
incorporation of Rpb1-Δlid2 into Pol II complexes. The Rpb1 subunit of Pol II-Δlid2 
presented here serves as an example for transcriptionally incompetent Pol II mutants 
that appear to be quickly degraded while the wild type copy of Rpb1 can rescue cell 
viability. Hence purification of transcriptionally incompetent mutant Pol II enzymes is 
currently not possible, unless target protein levels and stability are significantly in-
creased. Consistently a stabilisation could not be achieved by simple overexpression 
and purification also failed in the case of studies of mutant Rpb2 (Domecq et al., 
2010). 
3.2.4.3 Example of a functional mutation: Pol II with an F loop mutation 
was successfully purified 
The F loop is an element in bacterial RNA polymerase that is directly adjacent N-
terminally to the bridge helix and contacts the trigger loop. It allosterically controls 
catalysis of nucleotide addition (Miropolskaya et al., 2009). Among eukaryotic RNA 
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polymerases there are sequence variations in the region homologous to the F loop in 
bacterial RNA polymerases. The F loop might be involved in intrinsic cleavage stimu-
lation and its respective residues could contribute to the strong intrinsic cleavage ac-
tivities observed for Pol I and Pol III, in contrast to Pol II (1.5.1). Within the research 
project of Wenjie Ruan (Patrick Cramer laboratory), the effect of sequences of the 
Pol III F loop on RNA cleavage stimulation via interaction with Rpb9 in the context of 
Pol II was to be studied. Therefore five non-conserved residues of the F loop in Rpb1 
were mutated to the corresponding Pol III residues (Figure 28), obtaining Rpb1-FIII. 
Cloning of the mutant was performed as described (3.2.4.1) and plasmid shuffling 
using 5-FOA (2.2.2.6) revealed the FIII mutant to be viable with a growth phenotype 
comparable to cells without F loop mutation (Figure 29). The variant of Pol II was 
successfully purified (2.2.4.3) with a yield of 0.6 mg Pol II-FIII per 100 g cells, which 
is lower than the typical yield for wild type Pol II but a reasonable yield that allows us 
to conduct functional and crystallographic studies of the mutant enzyme. Upon sepa-
ration and visualisation of purified Pol II-FIII subunits by SDS-PAGE and Coomassie 
staining (2.2.8) it was found that one subunit is present in clearly substoichiometric 
amounts compared with wild type Pol II (Figure 30, lanes 2, 4). To prepare the Rpb9-
 
Figure 28: Construct design of the Pol III F loop variant in Pol II. 
An alignment of Rpb1 (grey) and its Pol III homolog Rpc1 (green) is shown. Five non-
conserved residues within the Rpb9 interacting region (orange) were replaced by the corres-
ponding Rpc1 residues to result in Rpb1-FIII.
 
Figure 29: F loop mutation is viable in S. cerevisiae. 
Serial dilutions of yeast cells on a YPD plate (left) and a 5-FOA plate (right). Three repre-
sentative clones of both the FIII mutant show the same growth phenotype on a 5-FOA plate. 
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deleted strain BJ5464 Rpb3 His-Bio Δrpb9 (2.1.1, Table 4) the natNT2 cassette was 
amplified from pFA6a-natNT2 (2.1.2, Table 6) and introduced into BJ5464 Rpb3 
His-Bio (2.1.1, Table 4) by homologous recombination (2.2.2.3.3.1) to replace the 
RPB9 ORF. From this strain Pol II lacking subunit Rpb9 was purified. A comparison 
of Pol II-Δrpb9 and Pol II-FIII (Figure 30, lanes 3, 4) confirms that the substoichiomet-
ric subunit in Pol II-FIII is Rpb9. It was probably partially lost during the process of 
purification due to reduced binding affinity of Rpb9 to Pol II comprising the mutated F 
loop. In vitro the functional enzymatic activity of Pol II-FIII was shown in RNA cleav-
age experiments performed by Wenjie Ruan. Fusion proteins of Rpb9 and its ho-
mologous Pol III subunit C11 (1.5.1) were previously found to stimulate a strong 
cleavage activity in Pol II-Δrpb9 (Ruan et al., Manuscript submitted). Upon incubation 
of Pol II-FIII with cleavage stimulating Rpb9–C11 fusion proteins (Ruan, in 
preparation) shortened RNA products resulting from RNA dinucleotide cleavage (1.5) 
are produced (Figure 31). 
   
 
Figure 30: Rpb9 is not stably bound to Pol II-FIII. 
4–12 % SDS-PAGE (2.2.8) showing wild type (wt) Pol II, Pol II lacking subunit Rpb9 (Δrpb9)
and Pol II-FIII. Subunit Rpb9 is present in substoichiometric amounts in Pol II-FIII (arrow).
The gel showing Pol II-FIII was conducted by Wenjie Ruan. 
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Pol II-FIII was successfully cloned and purified and its enzymatic activity was con-
firmed in vitro. Pol II-FIII is a functional enzyme bearing a mutation in Rpb1 that 
stands as an example for other functional Rpb1 mutations that can be produced with 
this established method. 
 
 
Figure 31: Pol II-FIII is active in stimulated RNA cleavage assays. 
An RNA cleavage scaffold containing a G-G mismatch at position +1 was incubated with
Pol II-FIII without or with Rpb9 or Rpb9-C11 fusion proteins. The dinucleotide cleavage prod-
uct is labelled (-2). The bead-based cleavage experiment and the gel depicted here were
conducted by Wenjie Ruan essentially as described (Sydow et al., 2009). Details about the
experimental procedure, cleavage scaffold and fusion proteins can be found elsewhere
(Ruan, in preparation).
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4 Follow-up experiments and conclusions 
Within this work the RdRP activity of purified S. cerevisiae Pol II was characterised in 
vitro. Pol II can synthesise RNA in an RNA-templated manner, but the activity is 
much slower and less processive than the DNA-dependent one. To perform efficient 
replication of the HDV antigenome human Pol II is probably extrinsically stimulated. 
HDAg, the only protein encoded by HDV was found to stimulate Pol II transcription 
activity in nuclear extracts of human cells (Yamaguchi et al., 2001). However it is not 
clear if other factors are involved in this stimulation. Therefore the effect of recombi-
nantly expressed HDAg on RdRP activity of purified Pol II was tested in vitro. Stimu-
lation could not be observed, presumably because yeast and not human Pol II was 
used or more probably due to the fact that HDAg was recombinantly expressed, thus 
lacking host-specific posttranslational modifications. This result is consistent with the 
finding that recombinant HDAg could promote HDV RNA replication only from the 
genomic but not from the antigenomic strand (Sheu & Lai, 2000). Generally it could 
be that other factors not related to HDAg can positively stimulate the RdRP activity of 
Pol II either alone or cooperatively with HDAg. To look for such an activity, yeast nu-
clear extracts were prepared with the help of Martin Seizl and roughly fractionated. 
Upon addition of nuclear extract components to a Pol II RdRP assay, stimulation of 
Pol II could not be observed but rather RNA degradation due to RNases present in all 
nuclear fractions. Addition of commercial RNase inhibitors could not prevent RNA 
degradation efficiently without as well inhibiting Pol II activity. 
As Pol I and Pol III are closely related to Pol II and as Pol I was already implicated in 
HDV replication, it seemed likely that they also have RdRP activity in vitro. In an in 
vitro RNA elongation assay using the HDV scaffold that is efficiently elongated by 
Pol II (3.1.2.1, Figure 10) RNA dinucleotide cleavage was observed upon incubation 
with Pol I (provided by Claus-D. Kuhn) and NTPs, indicating that Pol I can as well 
bind to the scaffold but its putative RdRP activity is much weaker than its RNA hy-
drolysis activity. Pol III (provided by Alessandro Vannini) did neither show strong 
elongation nor any cleavage activity, but definitive conclusions cannot be made from 
this experiment as Pol III was also very limitedly active in a DdRP control experiment, 
probably because the Pol III purification protocol was not yet optimised at the time of 
the experiment (A.V., personal communication). Thus, the roles of RNA polymerases 
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in HDV replication and in other cellular RdRP-involving processes, in consideration of 
other non-related RdRPs found recently in human (Maida et al., 2009) and Droso-
phila (Lipardi & Paterson, 2009) still have to be clarified in detail. 
As shown in this work Pol II could not elongate RNA stem-loops with a preformed 
stem longer than 13 bp. However during elongation of the HDV scaffold, elongation 
could proceed to the run-off corresponding to production of a stem with at least 
25 bp, which would even be much longer during HDV genome synthesis. It seems 
that a longer nascent stem-loop that is produced by Pol II itself is accommodated 
within the Pol II complex in a structurally different way than a preformed one. That an 
RNA containing a bulge can be elongated by Pol II suggests that the bulge can allow 
bypass of the blocking element in Pol II, presumably the lid loop. How the inhibitory 
effect of this blocking element is avoided in case of elongation of the HDV scaffold 
remains unresolved. To clarify whether the lid loop is the blocking element Pol II en-
zyme containing a lid truncation was desired to be produced. As lid deletion is lethal 
to yeast cells a rescue copy of Rpb1 must be present to enable cell viability. From 
such a strain lid-deleted Pol II could not be purified in consistence with results from 
studies of other lethal Pol II mutant enzymes (Domecq et al., 2010). 
An Rpb1 mutagenesis system was established within this work. Mutations can be 
conveniently introduced by standard cloning procedures on an Rpb1-encoding plas-
mid. Mutations that cause loss of cell viability can be easily identified by plasmid 
shuffling. Pol II enzymes comprising lethal mutations could not yet be successfully 
purified. To be able to inspect all kinds of possible mutations, access to purified en-
zymes with non-functional mutations in vivo is required. Neither endogenous expres-
sion nor induced overexpression of the protein containing a non-functional mutation 
enabled successful purification. Inhibition of cellular degradation of mutant Pol II 
might be the only possibility to obtain respective mutant enzymes from this 
mutagenesis system. A strain should be used that is specifically defective in Pol II 
degradation. The Pol II ubiquitylation pathway would be a suitable target to be dis-
rupted, affecting ubiquitylation-dependent Pol II degradation, while cell growth and 
protein production capabilities should at best not be negatively affected. Def1 is nec-
essary to degrade Pol II when transcriptionally stalled due to a DNA damage 
(Woudstra et al., 2002) or otherwise stalled during transcription elongation but does 
not affect stalled initiation complexes at promoters (Somesh et al., 2005). Upon a 
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double-knock out of ubiquitin-conjugating enzymes Ubc4 and Ubc5, Rpb1 was nei-
ther affected by degradation upon UV irradiation nor by polyubiquitylation upon tran-
scriptional arrest (Somesh et al., 2005). Elc1 is indispensable for formation of 
polyubiquitin chains at Rpb1 in vivo (Ribar et al., 2006) and in vitro (Harreman et al., 
2009). Thus Def1, Ubc4/Ubc5 and Elc1 are examples for possible candidates whose 
functions could be disrupted in the Rpb1 mutagenesis yeast strain. Putative defective 
degradation of mutant Rpb1 could lead to accumulation of Pol II containing mutant 
Rpb1, being a prerequisite for successful purification. Mutant Rpb1 in such strains 
could still be degraded by other pathways. Additionally secondary effects could oc-
cur, as transcriptionally incompetent Pol II enzymes that cannot be degraded might 
block the road on DNA hindering read-through of the wild type enzyme, thus leading 
to inefficient transcription and translation, which could be counterproductive for suc-
cessful purification with suitable yields. However these effects cannot be predicted 
and should be approached experimentally. Instead of disturbing enzymatic functions 
that covalently link ubiquitin to Rpb1 the attachment point at Rpb1 could be removed. 
Rpb1 residue lysine 695 was found to be a ubiquitylation target in Pol II (Peng et al., 
2003) and thus this and/or other residues could be mutated to remove targets for 
Pol II ubiquitylation in the mutated version of Rpb1 but Pol II complexes containing 
wild type Rpb1 would not be affected and the general effect on yeast viability should 
be milder than when disrupting functions of enzymes that might play roles in several 
cellular processes. 
A completely different approach to produce Pol II mutants would be reconstitution of 
subunits recombinantly expressed in E. coli. Although not possible so far in case of 
Pol II this approach is feasible for archaeal RNA polymerase (Naji et al., 2007; 
Werner & Weinzierl, 2002). One technical difficulty to express Pol II subunits in E. coli 
is the size of large subunits, which comprise 192 kDa and 139 kDa for Rpb1 and 
Rpb2, respectively. Although concerning primary sequence archaeal RNA poly-
merase is highly similar to Pol II, a main difference is the subunit composition as both 
Rpb1 and Rpb2 correspond to two distinct subunits each in archaeal polymerase 
namely A’ + A’’ and B’ + B’’, respectively (Naji et al., 2007; Werner & Weinzierl, 
2002). This split into smaller subunits facilitates expression in E. coli. It could be tried 
to analogously split subunits Rpb1 and Rpb2 to form smaller transcriptional and 
translational units and to assemble Pol II from 14 subunits. If all domains are properly 
folded such an enzyme could be transcriptionally active, but little differences in its 
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activity due to lack of subunit connections should be carefully considered especially 
in detailed mechanistic studies. 
Lethal Pol II mutants cannot be purified and thus cannot be studied in binding or ac-
tivity assays yet. Mutants that are functional can be cloned and purified using the 
Rpb1 mutagenesis system established in this work. A mutation in the F loop that was 
presented here as an example is active in RNA cleavage assays. Furthermore muta-
tions affecting number of CTD repeats, introducing a TEV cleavage site N-terminal of 
the CTD, clamp coiled coil mutations in the region interacting with Spt4/5 and muta-
tions in the Pol II pore influencing Pol II cleavage activity have successfully been 
cloned, partially purified and tested for activity, partially by other research group 
members. The Rpb1 mutagenesis yeast strain designed for array analyses is also in 
use. In summary, a well-working mutagenesis system for Rpb1 has been established 
during this work and could already be reproduced for Rpb2 with technical assistance 
of Stefanie Etzold. Taken together, studies of non-lethal mutations in 64 % of the 
mass accounting for Pol II, including the active site region and the most important 
functional elements are now available. Pol II lacking subunit Rpb9, that was also pro-
duced during this work can be complemented with recombinant Rpb9 variants, ena-
bling mutant studies of a third subunit of Pol II. 
A mutagenesis system of Rpb1 and Rpb2 that is probably generally applicable for all 
kinds of non-lethal mutations was established. Upon fermentation and purification 
Pol II mutants can be obtained in reasonable yields. An expansion of the system to 
have access to purified proteins containing also lethal mutations as suggested above 
could allow for all variants of mutants thus strengthening the system even more. With 
the system that is now at hand, binding and mechanistic studies of Pol II concerning 
many different topics are much faster and easier accessible than before. 
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6 Abbreviations 
5-FOA 5-fluoroorotic acid 
°C degree Celsius 
Å Ångstrom 
Amp ampicillin 
APS ammonium peroxodisulfate 
ATP adenosine 5’-triphosphate 
b base 
bp base pair 
BSA bovine serum albumin 
ccc clamp coiled coil 
C-H6 C-terminal hexahistidine tag 
C-H10 C-terminal decahistidine tag 
CSM complete supplement mixture 
CTD C-terminal domain 
CTP cytidine 5’-triphosphate 
cv column volume 
Da dalton 
DdRP DNA-dependent RNA polymerase 
DNA deoxyribonucleic acid 
dNTP deoxynucleoside triphosphate 
DMSO dimethylsulfoxide 
DTT dithiothreitol 
E. coli Escherichia coli 
EC elongation complex 
EDTA ethylene diamine tetraacetic acid 
e.g. for example [Latin: exempli gratia] 
et al. and others [Latin: et alii] 
EtOH ethanol 
FAM 6-carboxyfluorescein 
GTP guanosine 5'-triphosphate 
h hour 
HDAg hepatitis delta antigen 
HDV human hepatitis delta virus 
HEPES 2-[4-(2-hydroxyethyl)-1-piperazinyl]-ethanesulfonic acid 
His histidine 
I intensity 
i.e. that is [Latin: id est] 
IPTG isopropyl-β-D-thiogalactopyranoside 
LB lysogeny broth 
Leu leucine 
l litre 
M molar (mole/litre) 
MES 2-(N-morpholino)ethanesulfonic acid 
min minute 
MOPS 3-(N-morpholino)propanesulfonic acid 
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Mr relative molecular mass 
mRNA messenger RNA 
MWCO molecular weight cut off 
N-H10-(SA)5 N-terminal decahistidine-penta(serinylalanine) tag 
NF non-fluorescent 
Ni-NTA nickel-nitrilotriacetic acid 
Nl normal litre 
nt nucleotide 
NTP nucleoside triphosphate 
OAc acetyl-oxy 
OD600 optical density at 600 nm 
ORF open reading frame 
p.a. for analysis [Latin: pro analysi] 
PCR polymerase chain reaction 
PEG poly(ethylene glycol) 
PI protease inhibitor 
PMT photomultiplier tube 
Pol polymerase 
Pwo Pyrococcus woesei 
R residual index 
RdRP RNA-dependent RNA polymerase 
RNA ribonucleic acid 
RNase ribonuclease 
Rpb RNA polymerase B subunit 
Rpb4/7 heterodimer Rpb4 and Rpb7 
RNAi RNA interference 
rpm revolutions per minute 
rRNA ribosomal RNA 
RT room temperature 
SC synthetic complete 
S. cerevisiae Saccharomyces cerevisae (baker’s yeast) 
SDS-PAGE sodium dodecylsulfate polyacrylamide gel electrophoresis 
SLS Swiss Light Source 
ssDNA single stranded DNA 
T temperature 
Taq Thermus aquaticus 
TB transcription buffer 
TBE tris-borate-EDTA 
TBP TATA-binding protein 
TCA trichloroacetic acid 
TCEP tris(2-carboxyethyl) phosphine hydrochloride 
TE tris-EDTA 
TEMED N,N,N',N'-tetramethylethylenediamine 
Tet tetracycline 
TF transcription factor 
TFB-I, TFB-II transformation buffer I and II 
Tris  tris-(hydroxymethyl)-aminomethane 
tRNA transfer RNA 
Trp tryptophane 
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U unit 
Ura uracil 
UTP uridine 5'-triphosphate 
v/v volume per volume 
w/v weight per volume 
× g times gravity 
YNB yeast nitrogen base without amino acids 
YP yeast extract peptone 
YPD yeast extract peptone dextrose 
 
Bases in nucleic acids: 
A adenine 
C cytosine 
G guanine 
T thymine 
U uracil 
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